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61. ABSTRACT
To elucidate the significance of canine and feline gastric helicobacters in the etiology
of gastritis, five studies were performed.  Diagnostic methods for detecting helicobacters:
brush cytology, urease test, histologic examination, transmission electron microscopy
(TEM), and bacterial culture, were compared in 10 apparently healthy dogs and cats.  A
detailed topographical mapping of helicobacters in the stomach was performed on these
same 10 dogs and cats to find the most representative regions for sample-collection.  The
prevalence and colonization density of canine gastric helicobacters as well as their
association with gastric inflammation were then investigated in 25 clinically healthy dogs
and  in 21 dogs with upper gastrointestinal signs.  Helicobacter species were identified by
TEM and by culture, with evaluation of the association between number of Helicobacter
species and degree of gastric inflammation.  The efficacy of human triple therapy on the
eradication of gastric helicobacters, on clinical signs, and on gastric histology was assessed
in nine dogs with upper gastrointestinal signs; the recurrence of the bacteria after
successful eradication was evaluated in four of these dogs.  Finally, the transmission of
gastric helicobacters from two dams to their eight puppies and between the puppies was
studied.
 For demonstrating gastric helicobacters, brush cytology was the most sensitive
method.  The urease test and histologic examination revealed helicobacters less often only
in the antrum, and therefore were also of value.  TEM revealed helicobacters in 90 to100%
of all cases, and culture in 40% and 17% of the positive cases in dogs and cats,
respectively.  TEM and culture, although laborious and more expensive, are needed for
accurate identification of  Helicobacter species.
The prevalence of gastric helicobacters was 60% in healthy cats, and 100% in
healthy and  95% in affected dogs.  No significant differences were detected in
colonization density of helicobacters between healthy and affected dogs.  Gastric
Helicobacter species identified in dogs included H. bizzozeronii, H. felis, and H.
salomonis; mixed infections were common.  No significant association appeared between
number of colonizing Helicobacter species and inflammation.   H. bizzozeronii-like
organisms and H. felis were identified from cats.
Gastric helicobacters were detected less frequently (P<0.01) and more superficially
(P<0.05) in the antrum than in the cardia, fundus, and corpus in dogs but not in cats.  The
colonization density of helicobacters was also lowest in the antrum of dogs (P<0.001).
One sample from the cardia, fundus, or corpus should thus be sufficient to demonstrate the
organisms.
 Mononuclear cells, neutrophils, eosinophils, and  lymphocyte aggregates appeared
both in clinically healthy and in dogs with upper gastrointestinal signs; mononuclear cells
and neutrophils were relatively evenly distributed throughout the stomach.  Degree of
gastric inflammation did not differ significantly between healthy and affected dogs.
7Colonization density of helicobacters was not associated with degree of gastric
inflammation.  In cats, lymphocyte aggregates were found only in helicobacter-positive
cats, which also had more lymphocytes in the fundus and corpus than did helicobacter-
negative cats (P<0.05).
Dogs commonly showed histologic changes comparable to those of mild chronic
gastritis or of mild active chronic gastritis with the histologic criteria of human gastritis.
Mild chronic gastritis was found in the antrum of all healthy cats, and more often (P<0.01)
in the antrum than in other regions.  Cats also showed a significant (P<0.05) association
between helicobacters and chronic gastritis in the fundus and corpus.  With the newly
developed visual analogue scale for grading canine and feline gastritis, gastritis was also
a common diagnosis, although it appeared more rarely in healthy dogs than in affected
dogs (P<0.05).  No macroscopic or microscopic evidence of gastric or duodenal ulcers was
detected in any dog or cat.  Atrophy and dysplastic epithelial changes were diagnosed in
only a few clinically healthy and affected dogs.  In cats, helicobacters may cause histologic
changes comparable to those of chronic gastritis, but in dogs this association remained
unclear.  It still remains to be determined whether certain strains of  Helicobacter species
may induce canine gastritis.
Human triple therapy (amoxicillin, metronidazole, and bismuth subcitrate),
eradicated gastric helicobacters in 8/9 positive dogs.  One dog was successfully treated
with tetracycline and omeprazole after unsuccessful eradication with triple therapy.
Eradication of helicobacters alleviated clinical signs (P<0.05) but did not resolve them
totally in any dog; additional therapies after triple therapy alleviated clinical signs further
(P<0.01).  Neither triple therapy nor additional therapies had a significant effect on gastric
histologic changes. Gastric helicobacters recurred within three years of eradication
treatment.  Because gastric helicobacters alone do not appear to be responsible for upper
gastrointestinal signs  in dogs,  routine eradication treatment seems not to be warranted. 
During a challenge study with H. bizzozeronii, puppies of the non-challenged group
that originated from two dams having an eradicated  H. salomonis infection before delivery
were found to be infected with H. salomonis despite strict isolation and hygienic
procedures.  H. salomonis isolates of dams and puppies studied by ribotyping (HaeIII, ClaI
or PstI) and pulsed-field gel electrophoresis (PFGE) of NotI digests, showed that those in
dam B and in non-challenged puppies were identical.  Because H. salomonis isolates were
metronidazole-resistant, the eradication therapy of the dams before delivery had merely
suppressed their helicobacter infection.  Hence, puppies may acquire gastric helicobacters
from their dams during the lactation period, and puppies can infect each other during their
early life. 
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93. TERMINOLOGY, DEFINITIONS, AND ABBREVIATIONS
In this thesis, terms used for describing anatomic regions of the stomach are cardia,
fundus, corpus, antrum, and pylorus, according to the Illustrated Veterinary Anatomical
Nomenclature (Schaller 1992).  In the literature, the terms “body” and “fundus” are often
used instead of “corpus”.  Because this thesis focuses on gastric helicobacters only, the
term “helicobacters”, although not preceded by the term “gastric”, always refers to those
of the stomach.  The terms “positive” and “negative” refer to helicobacter-positivity or -
negativity.  The term “gastritis” is a histologic diagnosis, not a clinical diagnosis.  The
expression “upper gastrointestinal signs” refers to clinical signs the patient is showing,
such as nausea, vomiting, and abdominal pain.  Of the gastric helicobacter species,
Helicobacter pylori refers always to that of human beings if not mentioned otherwise.
The following abbreviations appear in the text:
ALP, alkaline phosphatase
ALT, alanine aminotransferase
BabA, blood group antigen-binding adhesin
BHI, brain-heart infusion
BP, biochemistry panel
CBC, complete blood count
CCUG, culture collection of the University
of Gothenburg
CFU, colony-forming units
DNA, deoxyribonucleic acid
EIA, enzyme immunoassay
ELISA, enzyme-linked  immunosorbent
assay
cagA, cytotoxin-associated gene A
HE, hematoxylin and eosin
HPF, high-power field (400x magnification)
HpSA, H. pylori antigen in stools
IL-8, interleukin-8
ISH, in situ hybridization
i.m., intramuscular
i.v., intravenous
MALT, mucosa-associated lymphoid tissue
MGG, May-Grünwald-Giemsa
MRU, modified rapid urease
NSAID, non-steroidal anti-inflammatory
drug
PAF, platelet-activating factor
PPI, proton-pump inhibitor
PCR, polymerase chain reaction
PFGE, pulsed-field gel electrophoresis
REA, restriction enzyme analysis
RNA, ribonucleic acid
SEM, scanning electron microscopy
TEM, transmission electron microscopy
UBT, urea breath test
VacA, vacuolating cytotoxin A
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4. INTRODUCTION
Chronic vomiting is a common gastrointestinal complaint in dogs and cats, and is
often  linked to chronic gastritis; spiral bacteria have been suggested as one etiologic factor
for chronic gastritis (Guilford and Strombeck 1996).  Spiral-shaped microorganisms were
observed originally as early as the end of the 19th century within the stomachs of animals
(Rappin 1881).  Rappin (1881) found helicobacters in the gastric mucosa of a dog, and his
work was confirmed by Bizzozero (1893) and  Salomon (1896) in dogs, cats, and rats.
These bacteria were first named Spirillum (Rappin 1881) or Spirochete (Lockard and Boler
1970), then they were classified Campylobacter, and now they belong to the genus
Helicobacter (Owen 1998).  At least four Helicobacter species may colonize the canine
and feline stomach: Helicobacter felis (Lee et al 1988, Paster et al 1991), Helicobacter
bizzozeronii (Hänninen et al 1996), Helicobacter salomonis (Jalava et al 1997), and
“Flexispira rappini” (also called “Helicobacter rappini”) (Lockard and Boler 1970, Eaton
et al 1996, Jalava et al 1998).  Mixed infections are common in dogs and cats (Lockard and
Boler 1970, Lee et al 1988).  What has not been clarified is whether any one Helicobacter
species is more pathogenic than another, or whether a mixed infection differs from that of
one species.  Dogs are not found to be naturally colonized with human Helicobacter pylori
(formerly Campylobacter pylori).  However, H. pylori has been shown to colonize
gnotobiotic dogs in an  experimental infection model (Radin et al 1990).  One study reports
H. pylori in commercial vendor cats (Handt et al 1994).  “Helicobacter heilmannii”
(formerly “Gastrospirillum hominis”), the second species detected in humans in a minority
of cases (McNulty et al 1989a, Solnick et al 1993, Andersen et al 1996 & 1999), resembles
by morphology H. bizzozeronii, and it has been speculated whether these are one and the
same species.  A recent detailed comparative analysis of a human isolate of other
helicobacters revealed that the cultured human “H. heilmannii” strain examined (Andersen
et al 1999) was in all characteristics identical to H. bizzozeronii (Jalava et al 1999a).  An
interesting suggestion has also been made that some reports of “H. heilmannii” may
represent in vivo growth of H. pylori based on different morphology of the single strain of
bacteria when it was grown on blood agar plates or in broth cultures (Fawcett et al 1999).
The genus of Helicobacter includes at least 18 formally described species and several
novel species that have not been validly named (Fox and Lee 1997, Owen 1998, Wadström
and Hänninen 1999).  Several Heliocbacter species have been described from gastric
mucosa also of other animals than the dog and cat, including Helicobacter mustelae in
ferrets, “Gastrospirillum suis” in pigs, Helicobacter nemestrinae in monkeys, and
Helicobacter acinonyx (acinonychis) in cheetahs (Fox and Lee 1997).  In addition to the
gastric mucosa, helicobacters have been isolated from the intestine and liver, such as
Helicobacter canis from the intestine and liver of dogs (Stanley et al 1993, Fox et al
1996a), Helicobacter cinaedi from the intestine of humans and hamsters (Totten et al 1985,
Gebhard et al 1989), Helicobacter muridarum and Helicobacter rodentium from the
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intestine of mice (Lee et al 1992a, Shen et al 1997), Helicobacter trogontum from the
intestine of rats (Mendes et al 1996), Helicobacter pametensis from the intestine of birds
and swine (Dewhirst et al 1994), Helicobacter pullorum from the intestine and liver of
poultry and from the intestine of humans (Stanley et al 1994), Helicobacter bilis from the
liver and intestine of mice (Fox et al 1995), Helicobacter hepaticus from the liver of mice
(Fox et al 1994), and Helicobacter cholecystus from the liver of hamsters (Franklin et al
1996).
Human H. pylori has been studied keenly for the past 15 years since its culture from
man in 1982 and the discovery that it may cause gastritis (Warren 1983, Marshall 1983).
Later, it was demonstrated that H. pylori plays an important role in the etiology of human
dyspepsia, gastritis, and gastroduodenal ulceration (Marshall and Warren 1984, Goodwin
et al 1986, Graham 1989, Sipponen et al 1993), and is a risk factor for gastric carcinoma
and lymphoma (Parsonnet et al 1991, Sipponen et al 1992).  Interest in canine and feline
gastric helicobacters began to increase a few years ago when the strong association of H.
pylori in man with gastric diseases became evident and universally accepted, and at
present, these bacteria are under intensive study.
Colonization of the gastric mucosa of dogs and cats with large spiral helicobacters
is common (Weber et al 1958, Henry et al 1987, Geyer et al 1993, Hermanns et al 1995,
Eaton et al 1996, Yamasaki et al 1998).  In cats, helicobacters have been found more often
in adult than in juvenile cats (Weber et al 1958, Otto et al 1994), but in dogs this
association is unknown.  The true prevalence of gastric helicobacters among pet dogs and
cats has remained unclear because previous studies either have been performed on
laboratory animals (Weber et al 1958, Henry et al 1987), or the clinical background of the
pet dogs has been obscure (Geyer et al 1993, Hermanns et al 1995, Yamasaki et al 1998).
The route of transmission of gastric helicobacter in animals is also unknown.  Human H.
pylori is suspected to be transmitted in early life by oral-oral contact (Taylor and Blaser
1991), although the fecal-oral route is also suggested (Kelly et al 1994).  Close personal
contact seems to be an important factor in transmission of H. pylori.  Dogs usually live in
close social contact with each other; dams and puppies are especially in close contact
during the lactation period.  Dogs can therefore serve as an animal model for studying the
transmission of gastric helicobacters during the early weeks of life.
Diagnosis of H. pylori infection in man can established by brush cytology, the urease
test, histologic examination, electron microscopy, culture, serology, the urea breath test,
and molecular methods (de Boer 1997).  Of these methods, histologic examination, the
urease test, and electron microscopy have been used most commonly for detecting
helicobacters in animals.  Comparisons between diagnostic methods for human H. pylori
have been performed and reviewed from various angles (Chodos et al 1988, Brown and
Peura 1993, Cutler et al 1995, de Boer et al 1997, Cutler 1997, Onders 1997), but the
superiority of any one method has not been evaluated in animals.
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It has been assumed that canine and feline helicobacters may be responsible for
histologic changes seen in the stomach in conjunction with these organisms.  However,
such changes have been detected both in dogs and cats with upper gastrointestinal signs
and in clinically healthy dogs and cats (Weber et al 1958, Henry et al 1987, Lee et al
1992b, Geyer et al 1993, Otto et al 1994, Hermanns et al 1995, Yamasaki et al 1998).
Some of these conclusions have been drawn from studies on experimentally induced
helicobacter infections (Lee et al 1992b).  That the histologic definition of gastritis of dogs
and cats has varied from study to study has made comparison of results very difficult. 
Thus far, no study has given an unambiguous answer to the question whether canine and
feline helicobacters are of clinical importance.  Gastric helicobacters differing from canine
and feline ones have been associated with variable degrees of histologically verified
gastritis in their hosts, e.g., H. mustelae in ferrets (Fox et al 1986 & 1990), “G. suis” in
pigs (Mendes et al 1990), H. nemestrinae in monkeys (Bronsdon et al 1991), and H.
acinonyx (acinonychis) in cheetahs (Eaton et al 1993).
In humans, eradication of H. pylori is more effective in preventing recurrence of
gastroduodenal ulcers than is traditional treatment with acid blockers, and reinfection with
H. pylori is rare after successful eradication (Seppälä et al 1992, Labenz and Börsc 1994,
Uemura et al 1995).  The present recommendation for H. pylori eradication therapy
consists of amoxicillin or tetracycline with metronidazole, plus omeprazole or bismuth
subcitrate (European Helicobacter Pylori Study Group 1997).  Only a few preliminary
reports have been published on eradication therapy for canine and feline gastric
helicobacters (Lecoindre et al 1998) and none on its effect on gastrointestinal signs or
gastric histology.
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5. REVIEW OF THE LITERATURE
5.1.Canine and feline chronic gastritis
Histologically verified chronic gastritis is a poorly documented entity in dogs and
cats, although it is considered a common cause of chronic vomiting in these species.  The
prevalence of canine and feline chronic gastritis and its association with upper
gastrointestinal signs is, however, unknown.
Canine and feline gastritis may be classified as acute or chronic, based on the
inflammatory cell type; and as superficial or diffuse, according to distribution of the cells
(Guilford and Strombeck 1996).  Various classifications of chronic gastritis have been used
- including etiologic and histologic classification - which have overlapping
clinicopathologic features.  Etiologic classification is possible if the primary cause is
identified, such as food allergy, nonsteroidal anti-inflammatory drugs (NSAID), or uremia.
However, in most cases of chronic gastritis, the cause remains unknown (Guilford and
Strombeck 1996).  The fact that objective criteria for histologic assessment of canine and
feline gastric biopsy specimens do not exist causes confusion when results of different
studies are interpreted and compared. 
Histologic features evaluated include the type and amount of cellular infiltrate, the
area of mucosa affected and its topography, mucosal thickness, and amount of gastric
glands.  In acute gastritis, the number of neutrophils is increased.  According to dominant
cell-type, chronic gastritis may be divided into nonspecific (mononuclear cells),
eosinophilic (eosinophils), and granulomatous/ histiocytic (macrophages) gastritis, the first
being the most common.  Both atrophic gastritis, characterized by thinning of gastric
mucosa and reduced number of gastric glands along with increased numbers of
lymphocytes and plasma cells, and hypertrophic gastritis, characterized by mucosal
proliferation due to hypertrophy and hyperplasia of the foveolar and glandular epithelium
accompanied by variable amounts of fibrous tissue and inflammatory cells, are not as
common as nonspecific gastritis.
Chronic gastritis is often patchy, and therefore small gastric biopsy specimens are not
representative of the whole stomach (van der Gaag and Happé 1989).  Superficial gastritis
often heals whereas, severe diffuse gastritis, atrophic, and hypertrophic gastritis may
persist for months, even years (van der Gaag and Happé 1989).
5.2.Epidemiology and transmission of gastric helicobacters 
Prevalence of canine and feline helicobacters is high.  Prevalence rates of 86 to100%
in healthy dogs, 61 to 82% in dogs with upper gastrointestinal signs, 41 to100% in healthy
cats, and 56 to76% in affected cats have been reported (Weber et al 1958, Henry et al 1987,
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Geyer et al 1993, Otto et al 1994, Hermanns et al 1995, Eaton et al 1996, Papasouliotis et
al 1997, Yamasaki et al 1998, Neiger et al 1998, De Majo et al 1998).  Most dogs studied
have been adults of various ages, and the prevalence rate related to the age of the dogs is
unknown.  In cats, helicobacters have been found more often in adults than in juveniles
(Weber et al 1958, Otto et al 1994).  
Human H. pylori has a world-wide distribution, and its prevalence in healthy
asymptomatic persons is 15 to70% depending on age, race, and social status (Kosunen et
al 1989, Graham et al 1991, Mégraud 1993, Lambert et al 1995).  The infection rate seems
to be very low in younger children in many developed countries (Mégraud et al 1989,
Kontiainen et al 1994).  Epidemiological studies have demonstrated a correlation between
colonization and age, low socio-economic status, and overcrowding, particularly during
childhood (Webb et al 1994).  The occurrence of “H. heilmannii” is rare, its prevalence
being <1% (McNulty et al 1989a, Heilmann and Borchard 1991, Holck et al 1997).
 The transmission of H. pylori is likely to occur by multiple routes affected by local
conditions and behavior (Cave 1997, Mendall 1997).  In humans, close personal contact
seems to enhance the transmission of H. pylori, which is suspected to be transmitted by
oral-oral or fecal-oral routes, which are evidenced by isolation of H. pylori from saliva and
feces (Taylor and Blaser 1991, Thomas et al 1992, Kelly et al 1994, Fox et al 1996b).  In
animals, higher prevalence rates are suspected in those living in colonies in which
transmission is enhanced (Weber et al 1958, Henry et al 1987, Eaton et al 1996),
supporting the role of intimate contact in this transmission.  Dogs usually have close
contact with each other, such as dams and puppies during the lactation period.  Family
members have shown identical subtypes of the organisms studied by molecular methods
(Wang et al 1993, Vincent et al 1994), suggesting transmission between family members.
Otherwise, H. pylori isolates from different subjects show large genetic divergence; almost
all isolates represent unique types (Akopyanz et al 1992, Owen et al 1992).  Iatrogenic
transmission via biopsy forceps or endoscope is also possible when proper cleaning and
disinfection has not been performed (Langenberg et al 1990, Fantry et al 1995, Akamatsu
et al 1996, Cronmiller et al 1999).  Although water and vegetables have also been linked
to H. pylori transmission, more comprehensive studies are needed to evaluate the
importance of  these vehicles as reservoirs for H. pylori (Fox 1995).
A study reporting H. pylori in commercial vendor cats led to a suggestion that H.
pylori may be a zoonotic pathogen with transmission occurring from cats to humans
(Handt et al 1994).  However, H. pylori has not been isolated from the stray cats studied by
El-Zataari et al (1997).  Neither has there been any difference in H. pylori seropositivity
between subjects who have owned a cat and those with other pets; this fails to support the
hypothesis that H. pylori may be transmitted from cats to humans or that cat owners may
have a higher risk of H. pylori infection than does the general population (Ansorg et al
1995, Webb et al 1996).
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An assumption for  zoonotic transmission of “H. heilmannii”-like helicobacters
from dogs and cats to humans has been suggested by similar morphologic features of the
organisms found in humans suffering from upper gastrointestinal symptoms and in animals
handled by these persons (Lavelle et el 1994, Thomson et al 1994, Dieterich et al 1998).
The symptoms were resolved after clearance of these organisms (Lavelle et el 1994), or in
one case, only when helicobacter eradication therapy was instituted in both humans and the
animals (Thomson et al 1994).  However, this evidence has been based solely on similar
morphologic features; firm evidence of their identity should be based on genetic criteria
(Curry 1994, Kusters and Kuipers 1998).  It has also been suggested that animals may be
reservoirs in the transmission of “H. heilmannii”, because “H. heilmannii” infection has
been found associated with contact with dogs, cats, or domestic animals (Stolte et al 1994,
Meining et al 1998).  Recently, it has been established that the isolated strain of “H.
heilmannii” (Andersen et al 1999) and H. bizzozeronii represent the same species
according to their phenotypic characteristics, whole-cell protein profile, 16S rRNA gene
sequence, and DNA-DNA homology, and hence, this species can be transmitted from dogs
to humans (Jalava et al 1999a).  The possible risk of transmission of canine and feline large
helicobacters may, however, be relatively slight because the prevalence of “H.
heilmannii”-like bacteria (i.e., H. bizzozeronii) is high in pet dogs and cats, whereas the
prevalence of “H. heilmannii” in humans is low (Strauss-Ayali and Simpson 1999). 
5.3.Pathogenicity of helicobacters
Canine and feline gastric helicobacters have been suspected of inducing
histologically verifiable gastritis.  Histologic changes such as inflammation, lymphocyte
follicles, and  degeneration of the gastric glands and parietal cells in the presence of gastric
helicobacters have been assumed to indicate the pathogenicity of these organisms (Weber
et al 1958, Henry et al 1987, Lee et al 1992, Geyer et al 1993, Otto et al 1994, Hermanns
et al 1995).  However, such changes have been detected not only in dogs and cats suffering
from gastrointestinal  signs, but also in clinically healthy dogs and cats.  It has been
speculated that H. felis and H. bizzozeronii may differ in their pathogenicity, H. felis being
more pathogenic than H. bizzozeronii, based on their cytopathogenic effects (Peyrol et al
1998, Norris et al 1999).  In experimental animal models, H. felis has been demonstrated
to induce gastritis in rats and mice (Lee et al 1990, Fox et al 1991a & 1993) and similarly
H. pylori-induced atrophic gastritis in long-term infected mice (Lee et al 1993a).
However, although hard evidence of the pathogenicity of canine and feline gastric
helicobacters is still lacking, some features of human H. pylori may apply also to
helicobacters of animals.
Evidence that H. pylori plays a role in the pathogenesis of human gastritis comes
from volunteer studies, animal-model experiments, and therapeutic trials.  Acute gastritis
developed in two volunteers who ingested H. pylori (Marshall et al 1985, Morris and
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Nicholson 1987).  An experimental oral challenge of gnotobiotic piglets with H. pylori was
associated with persistent colonization of the stomach and transient infiltrates of the gastric
mucosa with neutrophils, followed by mucosal and submucosal infiltration with diffuse
and follicular infiltrations of mononuclear cells, as in human H. pylori infection
(Krakowka et al 1987).  Disappearance of gastritis after eradication of H. pylori  supports
the view that this organism plays a causal role in pathogenesis of chronic gastritis (Valle
et al 1991). There is also indirect or secondary evidence that supports the pathogenic role
of H. pylori such as association of the organisms with only gastric epithelial cells,
serologic response to infection, and lowering of antibody levels after eradication of the
bacteria (Blaser 1990).  Combining the pathogenetic data of H. pylori has clearly pointed
out the fact that H. pylori is a major human gastrointestinal pathogen (Blaser 1990,
Marshall 1991, Blaser et al 1992, Misiewicz 1992, Lee et al 1993b, Lambert et al 1995).
In addition to gastritis, human H. pylori has been recognized to be an important
etiologic factor also in gastroduodenal ulceration (Marshall and Warren 1984, Goodwin et
al 1986, Graham 1989, Sipponen and Hyvärinen 1993), and in gastric carcinoma and
primary gastric low-grade lymphoma of mucosa-associated lymphoid tissue type (MALT)
(Parsonnet et al 1991, Sipponen et al 1992, Sipponen 1994).  MALT lymphoma has also
been detected in association with “H. heilmannii” (Morgner et al 1997).
Gastric ulcers and tumors are rare in dogs and cats.  In dogs, NSAID are the most
common cause for gastric ulcers, which tend to be most frequent in the antrum  (Guilford
and Strombeck 1996).  A variety of stressful events may also induce gastric erosions and
ulcers, such as trauma, shock, sepsis, psychologic stress, and head injury.  Carcinoma and
lymphoma are the two most common types of gastric tumors, and are encountered most
often in older animals (Gualtieri et al 1999).   Of the Helicobacter species in animals, H.
mustelae in ferrets has been suggested to be associated with gastric adenocarcinoma and
gastric lymphoma (Fox et al 1997, Erdman et al 1997). 
5.3.1. Gastric histopathology
H. pylori-induced gastritis is characterized by accumulation of neutrophils,
lymphocytes, and plasma cells.  Human gastritis is classified as acute, chronic, or special,
and is graded according to morphological variables - H. pylori density, inflammation,
glandular atrophy, and intestinal metaplasia - each as normal, mild, moderate, or marked
(Price 1991, Dixon et al 1996).  In acute gastritis, neutrophils infiltrate the gastric mucosa,
whereas in chronic gastritis, the inflammatory cells consist of lymphocytes and plasma
cells.  Typically, H. pylori induces chronic active gastritis, and may also induce atrophy
and intestinal metaplasia (Blaser 1992, Rugge et al 1993, Sipponen and Hyvärinen 1993,
Kuipers et al 1995).  Lymphoid follicles are associated with H. pylori-induced gastritis;
they are found more frequently in the antrum than in the corpus, and on the lesser rather
than greater curvature (Genta et al 1993a, Zaitoun 1995).  The long-term course and
consequences of canine and feline helicobacters is unknown, whereas in humans it has
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been demonstrated that chronic H. pylori infection may heal spontaneously and
inflammatory changes in the gastric mucosa may resolve partially or totally, and new H.
pylori infection may occur in adulthood, although these events are rare (Niemelä et al
1995, Villako et al 1995, Valle et al 1996).  On the other hand, duodenal ulcer disease is
associated with persistent H. pylori infection, gastritis usually persists, and atrophic
gastritis as well as intestinal metaplasia may appear, and the risk for development of gastric
cancer may increase (Kuipers et al 1995, Niemelä et al 1995, Villako et al 1995, Valle et
al 1996). 
“H. heilmannii” has also been associated with gastritis which, however, is usually
less severe than H. pylori-induced gastritis (Heilmann and Borchard 1991, Holck et al
1997, Stolte et al 1997).  In addition, one study has reported “H. heilmannii” to be
associated with gastric ulcers (Debongnie et al 1998). 
Canine and feline helicobacters have been found throughout the stomach, most often
in the corpus, and are located superficially on the mucosal surface including gastric pits,
and deeper in gastric glands and in parietal cells (Henry et al 1987, Geyer et al 1993,
Yamasaki et al 1998).  H. pylori usually colonizes both the antrum and the body, but the
number of bacteria is usually higher in the antrum (Genta and Graham 1994, Stolte et al
1997), and the organisms are located within the mucus and in close proximity to epithelial
cells only (Hazell et al 1986, Thomsen et al 1990).  However, one study reports H. pylori
found also in parietal cells (Chen et al 1986).  “H. heilmannii” colonizes predominantly
the antrum, and is located primarily  on the mucosal surface but may also penetrate deeper
into gastric glands and even into parietal cells (Heilmann and Borchard 1991, Stolte et al
1997).
5.3.2. Mechanisms of tissue injury
Thus far, very little is known about the pathogenic properties of canine and feline
helicobacters.  The putative pathogenic determinants of human H. pylori can be divided
into maintenance factors and virulence factors (Dunn et al 1997).  Maintenance factors
allow the organisms to colonize and remain within the host, and include for instance
motility and adhesion to the gastric mucosa, and the production of urease enzyme.
Virulence factors contribute to the pathogenetic effects of the bacterium, and the main
effects are gastric inflammation, disruption of the mucosal barrier, and alteration of gastric
physiology. 
Their corkscrew-like motility, the spiral shape, and flagella of helicobacters allow
free movement in viscous gastric mucus, and therefore, motility is assumed to ease the
colonization of the organisms (Hazell et al 1986, Eaton et al 1992).  In an experimental
study with gnotobiotic piglets, the motile strains of H. pylori showed a 100% infection
rate, whereas aflagellated, nonmotile strains were unable to colonize (Eaton et al 1989).
Adherence to the gastric mucosa may play an important role in the colonization and
pathogenicity of H. pylori and H. mustelae but not H. felis (Taylor et al 1992).  Adhesion
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occurs by adhesins such as hemagglutinins and blood group antigen-binding adhesin, BabA
(Evans et al 1988, Taylor et al 1992, Kobayashi et al 1993, Ringner et al 1993, Clyne and
Drumm 1993 & 1997, Ilver et al 1998).  However, adhesion appears not to be essential for
colonization for all gastric helicobacters because for instance “H. heilmannii” and H. felis
do not attach but maintain a close proximity to the mucosa, presumably by their active
motility (Lee et al 1993b).
Gastric helicobacters of both humans and animals produce the urease enzyme which
hydrolyzes urea to ammonia, which raises gastric pH adjacent to the mucosa up to a level
where bacteria may survive (Marshall et al 1990), although this does not appear to be the
primary function of urease (Eaton et al 1994).  Hypochlorhydria may occur via parietal cell
failure, possibly due to direct or indirect toxic effects of the ammonia or due to the
organisms themselves, or via obstruction of the necks of the gastric glands by sloughed
epithelium, mucus, and inflammatory cells (Chen et al 1986, Graham et al 1988).  Parietal
cell acid secretion may also be inhibited by interleukin-1 (IL-1) which has been shown to
increase in H. pylori infection (Peek et al 1995, Beales and Calam 1998).  Additionally,
ammonium itself may be directly toxic to epithelial cells (Smoot et al 1990).  In an
experimental study, a urease-negative H. pylori strain did not colonize gnotobiotic piglets,
whereas a urease-positive strain did, indicating that urease activity appears to be essential
for colonization of H. pylori (Eaton et al 1991).  Acute H. pylori infection appears to cause
usually transient hypochlorhydria, promoting bacterial colonization before acid secretion
returns to normal (Morris and Nicholson 1987, Barthel et al 1988, Cave and Vargas 1989,
Graham et al 1988, Kelly et al 1993).  The period of hypoacidity (from weeks to months)
is probably of sufficient duration for the bacteria to colonize (Blaser 1990).  In ferrets, H.
mustelae also produces a transient elevation in gastric pH (Fox et al 1991b).
Mechanisms by which H. pylori may induce gastric inflammation consist of several
factors including interleukin-8 (IL-8) secretion, neutrophil adherence, platelet-activating
factor (PAF), and urease (Dunn et al 1997).  The inflammation caused by H. pylori is
suspected to be due to chemotactic factors, such as IL-8, induced by the bacterium, which
stimulate leukocyte accumulation (Craig et al 1992, Mai et al 1992, Nielsen and Andersen
et al 1992, Hatz et al 1996).  It has also been demonstrated that H. pylori strains possess
150-kDA protein, which increases neutrophil adherence to endothelial cells and
metabolizes the nonulcerogenic lyso-PAF into PAF, a phospholipid mediator which is a
potent ulcerogenic agent, and urease which stimulates mononuclear phagocyte activation
and inflammatory cytokine production (Dunn et al 1997).
Disruption of the protective gastric mucosal barrier may be due to phospholipases,
mucinase, and vacuolating cytotoxin produced by H. pylori as well as be due to induction
of the apoptosis (Dunn et al 1997).  Extracellular protease of H. pylori may alter the quality
the of the mucus layer by  reducing viscosity and making the layer thinner (Slomiany et al
1987 & 1988, Sarosiek et al 1988, Hills et al 1993), although it seems contradictory that
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helicobacters would destroy the mucus which is the natural habitat of these organisms (Lee
et al 1993b).
H. pylori strains may possess cytotoxin-associated gene A (cagA) which codes
production of CagA, an immunogenic protein (Dunn et al 1997). There is evidence that
cagA-positive H. pylori strains may be more infective and cause more inflammation than
cagA-negative strains (Gunn et al 1998).  An H. pylori gene, iceA (induced by contact
with epithelium), has recently been discovered, and of the two main variants, the iceA1
has also been associated with peptic ulceration and increased mucosal concentration of IL-
8, an inflammatory mediator (van Doorn et al 1998, Peek et al 1998).
All H. pylori strains possess the cytotoxin-coding vacA gene and approximately half
the strains produce a vacuolating cytotoxin A (VacA) which induces cytoplasmic
vacuoles in epithelial cells (Leunk et al 1988, Cover and Blaser 1992).  Neutralizing
antibodies against VacA cytotoxin have been detected in the serum of patients infected
with cytotoxin-producing strains (Cover et al 1992, Leunk et al 1990).  Most of the H.
pylori strains isolated from patients having gastric ulcers generate cytotoxin, but also a
significant number are negative for cytotoxin (Figura et al 1989).  The role of cytotoxin in
gastroduodenal ulcerogenesis is not fully known.  However, H. pylori strains of vacA s1a
type have been shown to produce the highest level of cytotoxin, and have been associated
with enhanced gastric inflammation and duodenal ulceration (Atherton et al 1995 & 1997),
whereas H. mustelae in ferrets has not been shown to produce cytotoxin in vitro (Morgan
et al 1991), although it causes gastritis in its host (Fox et al 1990).  In vivo vacuolization
is a nonspecific phenomenon, and thus may be attributable to normal epithelial turnover or
to inflammatory cell mediators because vacuoles may be present in both infected and
uninfected individuals, as shown in an experimental infection model (Eaton et al 1989).
It has been demonstrated that H. pylori induces alterations in the gastric epithelial
cells, including enhanced proliferation and increased programmed cell death, apoptosis
(Moss et al 1996).  H. pylori infection has also been shown to induce autoimmunity in
susceptible individuals, which may lead to corpus atrophy, loss of parietal cells and
consequent decrease in acid secretion, and increased gastrin levels as a reaction to
increased pH (Appelmelk et al 1998).
 Increased gastrin release, diminished responsiveness of parietal cells to gastrin, and
decreased somatostatin release lead to altered gastric physiology.  Colonization of human
H. pylori is associated with hypergastrinemia (Levi et al 1989a, Smith et al 1990, Prewett
et al 1991), parallel to H. mustelae in ferrets (Perkins et al 1996a). The suggested causes
for hypergastrinemia include suppressed antral somatostatin content (Kaneko et al 1992,
Moss et al 1992, Haruma et al 1995), stimulation of antral G cells by mediators of
inflammation (Mullholand et al 1993), especially in H. pylori-induced pangastritis (Valle
et al 1992, Götz et al 1995), and alkalinization of the gastric mucus layer by bacterial
urease (Chittajallu et al 1991).  Increased acid secretion reduces somatostatin secretion,
which in turn stimulates the secretion of gastrin (Blaser 1992, Lamers 1992).  It has also
20
been speculated that a high gastrin level increases secretion of hydrochloric acid which
may promote gastric metaplasia in the duodenum, offering a favorable environment for
helicobacters to colonize, and therefore a predisposition to duodenal ulcers (Misiewicz
1992).  The suggestion that increase in acid secretion occurs at the very beginning of the
infection and lasts for only a short period of time before development of hypochlorhydria
causes confusion in this matter (Graham et al 1988).
In experimental dogs infected with H. felis and in uninfected control dogs, the gastric
secretory axis, i.e., fasting, meal-stimulated, and pentagastrin-stimulated gastric acid
secretion, mucosal gastrin and somatostatin immunoreactivity, and fasting gastric pH, has
been reported to be similar, suggesting that H. felis may not be a gastric pathogen in dogs
(Simpson et al 1999).
Pepsinogen I and II concentrations have also been reported to be higher in  H. pylori-
positive compared to H. pylori-negative subjects (Mossi et al 1993).  Along with the
eradication of H. pylori, gastrin and pepsinogen concentrations normalize, indicating that
both hypergastrinemia (Levi et al 1989b, Graham et al 1990, Chittajallu et al 1992,
Verhulst et al 1995) and hyperpepsinogenemia (Fraser et al 1992, Di Mario et al 1996,
Gisbert et al 1996) are induced by H. pylori infection.
5.4.Diagnostic methods for detecting gastric helicobacters
Diagnostic methods to detect gastric helicobacters can be classified as invasive or
non-invasive.  Invasive methods require endoscopically obtained gastric biopsy specimens
or mucus and include brush cytology, the urease test, histologic examination, electron
microscopy, culture, the polymerase chain reaction techniques (PCR), and in situ
hybridization (ISH).  Noninvasive methods consist of serologic methods, the urea breath
test (UBT), and detection of bacteria, as well as bacterial DNA and antigens in stool.
Helicobacters can be visualized directly in a brush cytology sample, in histologic and TEM
specimens, and in cultured samples.  The presence of the organisms can demonstrated
indirectly by the urease test, serology, and UBT.  Serology and UBT are used in humans
for epidemiologic studies and in treatment monitoring of H. pylori infection.  In animals,
PCR, serologic methods, and UBT are not in routine use thus far. 
5.4.1. Quick tests
Brush cytology (Gad 1989, Mendoza et al 1993, Carmona et al 1995) is performed
by spreading gastric mucus on a slide which is then air dried and stained with
Romanovsky-type stain, if a rapid result is required, or with May-Grünwald-Giemsa
(MGG).  The spiral bacteria are readily seen under a microscope at 400x magnification.
Similarly, rapid diagnosis of helicobacters can be made by stained touch preparations of
mucosal biopsies (Montgomery et al 1988).  It has been suggested that “H. heilmannii” in
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humans may be better diagnosed by touch cytology than by biopsy specimens (Debongnie
et al 1995).
A typical feature of gastric helicobacters is that they are potent urease producers, and
the urease test reveals their enzyme production (Hazell et al 1987).  It is an easy, quick,
and inexpensive test to perform.  Gastric mucosal biopsy specimens are placed into a test
reagent containing unbuffered urea in distilled water and an indicator color for pH change.
Ammonia released by the urease enzyme causes a pH change, and subsequently, a color
change in the test reagent.  The time for a positive result is usually proportional to the
number of helicobacters, i.e., when a positive result is obtained rapidly it is likely that the
helicobacter count is high (Hazell et al 1987).  Several reports describe and compare urease
tests for the detection of human H. pylori (Borromeo et al 1987, Marshall et al 1987,
Goldie et al 1989, McNulty et al 1989b, Katelaris et al 1992).
 It has been stated that doubling the amount of tissue (size or number) in the urease
test hastens the positive result by approximately 1.5 to 2 hours (Laine et al 1996a).
Similarly, incubation of the urease test at 37bC has been shown to hasten the time to a
positive result in comparison to incubation at room temperature (22-24bC), and therefore
warming of the urease test is recommended when the final result of the test is desired
within 1 to 2 hours of biopsy, within which period this difference appears to be significant
(Laine et al 1996b).   Accidental blood in the biopsy specimen does not seem to alter
urease test results (Laine 1998).  The urease test has been reported to be less accurate in
human patients receiving H2-receptor antagonists (Lerang et al 1998).
5.4.2. Histology
Gastric biopsy specimens for histologic examination are usually fixed in buffered
formalin, embedded in paraffin wax, and sectioned.  Helicobacters can be visualized with
routine  hematoxylin and eosin (HE) staining, and with special stains such as Warthin-
Starry silver staining (Stevens 1990), Giemsa staining (Madan et al 1988), Genta staining
(Laine et al 1997), and alcian yellow/toludine blue staining (Leung et al 1996).  When HE,
Giemsa, and Genta stains were compared, it was found that Giemsa stain appeared to be
the preferred stain for H. pylori diagnosis, although the HE stain was also accurate when
bacterial density was high (Laine et al 1997).  The Warthin-Starry staining method is
sensitive for demonstrating spiral organisms, but it is more expensive and difficult to
perform and does not have any advantage over Giemsa staining (Barthel et al 1988, Madan
et al 1988).  Genta stain is also good  for helicobacter evaluation and allows visualization
of histologic features simultaneously, but it is a laborious and expensive method (El-
Zimaity et al 1998).  It has been shown that the Sayeed staining method also allows
simultaneous identification of helicobacters and visualization of tissue morphologic
features, and is inexpensive, quick, and easy to perform and interpret (Cohen et al 1997).
It may be difficult to detect helicobacters in a gastric biopsy specimen when the density of
the organisms is low (El-Zimaity et al 1998).   Histologically, in addition to demonstrating
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the presence and location of gastric helicobacters, lesions such as inflammation can be
evaluated.  Immunohistochemical staining techniques have also been shown to be sensitive
in detecting H. pylori in gastric biopsy specimens (Ashton-Key et al 1996).
5.4.3. Electron microscopy
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM)
reveal not only the presence of gastric helicobacters but also their typical morphology
(Weber and Schmittdiel 1962, Lockard and Boler 1970, Henry et al 1987, Lee et al 1988,
Geyer et al 1993, Handt et al 1994, Utriainen et al 1997).  The size of the bacterium,
number of coils, location, and presence of polar flagellae and periplasmic fibrils can be
evaluated by TEM and SEM.  Canine and feline gastric helicobacters have a tightly or
loosely coiled spiral morphology.  They possess bipolar multiple flagellae at their terminal
ends.  They may have periplasmic fibrils around the cell body, or the cell surface may be
smooth.  The size of the bacteria ranges from 5 to10 µm in length and from 0.3 to1.2 µm
in width.
At least four morphologically different Helicobacter species occur in biopsy
samples.  The first spiral organism is H. felis, which has one, two, or three periplasmic
fibrils around the cell wall (Lee et al 1988, Paster et al 1991).  The second, which does not
have fibrils, is H. bizzozeronii (Hänninen et al 1996).  The third, the loosely coiled or wavy
and rather thick H. salomonis, has been described recently (Jalava et al 1997).  The fourth
is “F. rappini”, a more cylindrical organism with numerous net-like filaments around the
cell body (Lockard and Boler 1970, Utriainen et al 1997).  Human “H. heilmannii” and the
newly described non-fibrillated H. felis (Eaton et al 1996) are highly similar to H.
bizzozeronii, based on their morphological features in TEM and SEM.  Therefore, electron
microscopy is not a sensitive enough method to draw conclusion as to similarity of these
species (Curry 1994).
5.4.4. Culture
Culture allows a detailed characterization of isolates and antimicrobial susceptibility
testing.  Several reports on culture techniques and growth media for H. pylori have been
published (Goodwin et al 1985, Veenendahl et al 1993, Hachem et al 1995).  Culture of
canine and feline gastric helicobacters is, however, difficult and laborious. An adequate
transport medium should be used, and rapid transportation of the biopsies to a
microbiological laboratory is essential for the viability of the bacteria (Veenendaal et al
1993, Xia et al 1993).  A freshly made brain-heart infusion (BHI) agar with horse blood
has been described as the first-choice recommendation for primary isolation of H. pylori
(Hachem et al 1995), and similar media with selective antibiotics have appeared most
suitable also for isolation of canine and feline helicobacters (Hänninen et al 1996).  The
plates are incubated microaerobically at 37bC up to 10 days because helicobacters grow
slowly. The bacterial growth is seen as a thin, spreading non-hemolytic film.
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Contamination of the plates is often encountered and can be minimized by fasting the
animals before sampling biopsies (Jalava et al 1998). 
5.4.5. Molecular methods  
PCR techniques can demonstrate helicobacter DNA from gastric biopsies even
when their number is too low to be detected by other methods.  This technique amplifies
a fragment of genomic DNA  from a given bacterium.   H. pylori has been detected with
this technique but is  usually not cultured from dental plaque, saliva, or feces (Banatvala
et al 1994, Li et al 1996).  Several primers have been designed for H. pylori chromosomal
DNA amplification (Ho et al 1991, Valentine et al 1991, Clayton et al 1992, Hammar et al
1992, Kong et al 1996).  The gene sequence 16S rRNA is highly similar between H. felis,
H. bizzozeronii, H. salomonis, and “H. heilmannii” and therefore does not seem suitable
as a target for species-specific PCR for discriminating among gastric helicobacters in
animals (Jalava et al 1997 & 1998, Norris et al 1999).  One study reports the use of PCR
with primers specific for the 26-kDa product in detection of helicobacters in cats after
eradication therapy (Perkins et al 1996b).  Currently, PCR is not in routine use in
veterinary medicine for detection of gastric helicobacters.
An in situ hybridization technique has been used successfully for identifying H.
pylori from formalin-fixed, paraffin-embedded tissue sections (Bashir et al 1994,
Karttunen et al 1996, Barret et al 1997, Park and Kim 1999).  In ISH methods, nucleic acid
probes are produced by selecting, cloning, and synthesizing genomic sequences specific for
a particular group of infectious agents; these probes in turn hybridize with DNA or RNA
targets in the clinical specimen (Tang and Persing 1999).
5.4.6. Serological tests
Serological tests measure circulating antibodies (IgG, IgA), formed by response to
gastric helicobacters, and these tests are accurate, relatively fast and simple to perform, and
fairly cheap.  Several methods are used to measure H. pylori antibodies, including bacterial
agglutination and complement fixation, latex agglutination, passive hemagglutination, and
immunoblotting tests (von Wulffen 1992).  However, the enzyme-linked  immunosorbent
assay (ELISA) is the most commonly used method because it is sensitive and easy to
perform, and therefore suitable for screening large populations in epidemiologic studies
(von Wulffen 1992).  Selection of an antigen is crucial in diagnostic serology, and in
general, three types of antigens have been used: crude antigens such as whole cells and
whole cell sonicates, cell fractions such as glycine extracts and heat-stable antigens, and
enriched antigens such as urease and a 120-kDa antigen (Dunn et al 1997).  Sensitive and
specific results have been gained by ultracentrifuged sonicate, acid glycine extracts, urease
preparations, and purified protein preparations as antigens (Hirschl et al 1988, von Wulffen
and Grote 1988, Czinn et al 1989, Evans Jr. et al 1989, Newell and Stacey 1989).  Serology
may also be used to monitor H. pylori eradication treatment, and a 20 to 50% reduction in
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IgG concentrations by six months after eradication therapy has been associated with
successful treatment (Kosunen et al 1992, Cutler et al 1993). Commercial kits are available
for H. pylori serology (Talley et al 1992), but not for animals.  Recently, a serologic
method has been described for diagnosing gastric helicobacters in dogs  (Strauss-Ayali et
al 1999).
5.4.7. Urea breath tests
The urea breath test (UBT) diagnoses helicobacter infection by demonstrating the
urease activity of the bacteria.  After an overnight fast, baseline breath samples are
obtained, and then radiolabeled urea is administered orally as a substrate.  Urea can  be
labeled with 13C, a nonradioactive isotope (Graham et al 1987, Logan et al 1991), or with
radioactive 14C (Marshall and Surveyor 1988, Veldhuyzen van Zanten et al 1990).  Exhaled
air is sampled usually 30 minutes after ingestion, and the level of radioactivity is measured
with a mass spectrometer (13C) or a scintillation counter (14C).  Safe and simple microdose
14C- and  13C-urea breath tests have also been validated in humans.  In these methods, a low
dose of urea is given orally in a capsule, and a single breath sample is collected after 10
minutes; the result can be obtained within 15 minutes if a counting instrument is nearby
(BielaÛski et al 1996, BielaÛski and Konturek 1996, Peura et al 1996).  UBT is useful in
for treatment monitoring, because after antimicrobial treatment and eradication of H.
pylori, serologically detected antibody titers show a diagnostic decrease after 5-6 months
(Kosunen et al 1992), whereas UBT becomes negative in only about a month (Marshall
and Surveyor 1988).  The disadvantages of the UBT are higher cost because of special
equipment and the requirement of a radioactive isotope if 14C is used.
The 13C-urea breath test has been evaluated in dogs and seems to provide a
noninvasive procedure to detect canine helicobacters (Cornetta et al 1998).  The 14C-urea
breath test has been used successfully to diagnose H. mustelae infection in ferrets and H.
felis infection in mice (McColm et al 1993, Glauser et al 1996).
5.4.8. Helicobacter detection in stool
Culture and PCR techniques have been used to detect H. pylori and its DNA in feces
(Kelly et al 1994, Gibson et al 1995, Makristathis et al 1999). In addition, enzyme
immunoassay (EIA) for detection of  H. pylori antigens in stool (HpSA) has recently been
described (Vaira et al 1999).  This noninvasive EIA method is commercially available
(HpSA Premier Platinum HpSA, Meridian Diagnostics, Cincinnati, OH, USA), and has
been shown to be a reliable tool and easy to use for diagnosing H. pylori infection.  One
report describes a PCR method for diagnosing helicobacters in feces as well as in dental
plaque of H. pylori-infected cats (Fox et al 1996b).  
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5.5.Identification and molecular typing of helicobacter isolates
Preliminary identification of Helicobacter species is made on the basis of
morphologic characteristics and motility determined in vivo by light microscope, and of
urease positivity.  Helicobacters are helical, gram-negative, actively motile, urease-,
oxidase- and catalase-positive organisms.  Accurate species identification requires
morphologic examination by electron microscopy,  biochemical, tolerance, and phenotypic
tests, as well as molecular methods on cultured helicobacters (Paster et al 1991, Hänninen
et al 1996, Jalava et al 1997).
Genotyping, a DNA-based typing of bacteria, uses microbial DNA as a target in
analyzing sequence variation and restriction sites at the whole genome level or at certain
loci.  Comparison of genotypes within species provides information on the genetic
relationship of strains.  This information can be used to trace the source of infection in
epidemics or, for example, to follow transmission of an infectious agent in a population of
animals or humans (Maslow et al 1993).  Methods used for genotyping include ribotyping
and pulsed-field gel electrophoresis (PFGE) (Tenover et al 1995).  In ribotyping, digested
DNA is hybridized with 16S rDNA, 23S rDNA or 16S + 23S rDNA probes.  In PFGE,
with the use of rare-cutting enzymes, a restricted number of fragments are produced which
are electrophoresed (Maslow et al 1993).
Molecular typing methods have been applied to study the diversity of H. pylori
isolates from various geographical areas (Akyopyanz et al 1992, Owen et al 1992).  Similar
methods have been used for typing of H. mustelae (Taylor et al 1994), H. bizzozeronii, and
H. salomonis (Hänninen and Hirvi 1999) as well as H. felis (Jalava et al 1999b).
5.6.Eradication therapy for gastric helicobacters
Studies concerning eradication therapy against canine or feline gastric helicobacters
are few but the preliminary studies, in which combinations of amoxicillin, metronidazole,
and famotidine or omeprazole were evaluated, indicate that human therapy effective for H.
pylori eradication may also apply to cats and dogs, although recurrent infections after these
therapies was also reported (DeNovo and Magne 1995, Perkins et al 1996, Cornetta et al
1998, Lecoindre et al 1998).  Multi-drug regimens have been shown to yield the best
eradication results in humans (Ciociola et al 1996, Unge 1996).  The regimes studied have
consisted of a bismuth preparation, an H2-receptor antagonist, or a proton-pump inhibitor
(PPI), in combination with one, two, or three antimicrobial agents (Rokkas et al 1988,
Unge et al 1989, Louw et al 1992, Hentschel et al 1993, Bell et al 1993, Yousfi et al 1995,
1996).  In the standard triple therapy, two antimicrobial agents: amoxicillin or tetracycline
in cases of penicillin allergy, and metronidazole, were combined with bismuth subcitrate
(Borody et al 1989).  In humans, the side-effects of this regimen, such as diarrhea, nausea,
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vomiting, or abdominal pain, may cause cessation of the therapy; therefore other regimens
aiming to fewer side-effects have been instituted (Bell et al 1993).
A recent recommendation for H. pylori eradication therapy involves a seven-day
treatment consisting of amoxicillin or tetracycline or clarithromycin with metronidazole,
plus omeprazole (PPI) or bismuth subcitrate (European Helicobacter Pylori Study Group
1997).  Combining omeprazole with two antimicrobials, amoxicillin, clarithromycin, or
metronidazole, and giving this twice daily for one week has been shown to produce a high
eradication rate of H. pylori, and to be well tolerated by the patients (Lind et al 1996).  The
European Society for Primary Care Gastroenterology (ESPCG) has recommended PPI,
clarithromycin, and amoxicillin  for eradication therapy of H. pylori infection in primary
care; however, awareness of the local resistance rates for metronidazole and clarithromycin
is essential for effective treatment (Rubin et al 1999).  Metronidazole resistance has been
reported as causing failures in eradication therapies containing this antimicrobial
component (Glupczynski et al 1990, Bell et al 1991, Noach et al 1994).  Primary resistance
may, however, be non-stable, explaining the discrepancy observed between results of in
vitro susceptibility tests and the eradication obtained in vivo (van Zwet et al 1995).  One
study reports that addition of omeprazole may reduce the impact of primary resistance of
H. pylori to metronidazole as well as to clarithromycin (Lind et al 1999).
It has been shown that eradicating H. pylori is more effective in preventing
recurrence of gastroduodenal ulcers than is traditional treatment with acid blockers and that
reinfection is rare after successful eradication (George et al 1990, Seppälä et al 1992,
Cutler and Scubert 1993, Labenz and Börsc 1994, Tytgat 1994, Uemura et al 1995).  This
has also been verified in two recent studies which demonstrated that omeprazole-
amoxicillin or metronidazole-clarithromycin one-week therapies were safe and effective
for eradication of H. pylori, healing and preventing relapse of gastric and duodenal ulcers
after successful eradication (Malfertheiner et al 1999, Veldhuyzen van Zanten et al 1999).
Indications for H. pylori eradication therapy have been given, and therapy is strongly
recommended, for instance, for peptic or bleeding ulcer disease; recurrent dyspepsia, and
gastritis with severe abnormalities (European Helicobacter Pylori Study Group 1997,
Rubin et al 1999).  Interestingly, MALT lymphomas associated with H. pylori or “H.
heilmannii” infections may resolve after cure of helicobacter infection (Chiang et al 1996,
Morgner et al 1997).
To confirm that the therapy has been successful, three large gastric mucosal samples
for biopsy are recommended to study the histology (El-Zimaity et al 1995).  To ensure the
total eradication of the bacteria, a check-up should be performed at the earliest 4 weeks
after therapy, and the use of more than one method for helicobacter detection is
recommended (van der Ende et al 1997).  Endoscopy and biopsy or 13C-UBTt have been
recommended as diagnostic tests for H. pylori infection, and  13C-UBT as the most useful
test for monitoring eradication (Rubin et al 1999).  The decrease in the number of
inflammatory cells occurs rather slowly: one to two years after H. pylori eradication, some
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increase in mononuclear cells can still be detected (Valle et al 1991, Genta et al 1993a).
A slow decrease in lymphoid follicles also occurs after eradication therapy (Genta et al
1993b). 
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6. AIMS OF THE STUDY
The purpose of this thesis was to establish the significance of canine and feline
gastric helicobacters in the etiology of gastric disorders.  The specific objectives were:
1. to compare brush cytology, the urease test, histologic examination, TEM, and culture
as diagnostic methods for detecting gastric helicobacters (I);  
2. to examine the prevalence and colonization density of gastric helicobacters in
clinically healthy pet dogs and cats and  in dogs with upper gastrointestinal signs (II, III);
3.  to perform a detailed topographic mapping of gastric helicobacters (II) in order to
discover the most representative regions for sample-collection for their detection (III);
4. to study the association between colonization densities of gastric helicobacters and
degree of gastric inflammation  in clinically healthy pet dogs and cats and  in dogs with
upper gastrointestinal signs in various gastric regions (II, III);
5. to identify gastric helicobacters by TEM as well as by culture (I - III) and to evaluate
the association between number of Helicobacter species and degree of gastric
inflammation (III);
6. to evaluate the efficiency of human triple therapy for the eradication of gastric
helicobacters, and its effect on clinical signs and on gastric histology, as well as to estimate
the recurrence of gastric helicobacters after eradication (IV);
7. to study the transmission of gastric helicobacters from dams to offspring and
between puppies (V).
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7. MATERIALS AND METHODS
7.1.Animals
To evaluate diagnostic methods and to perform topographic mapping, 10 dogs and
10 cats, recently euthanized, were acquired (Studies I-II).  All were apparently healthy pets
and had been euthanized at their owners' request (Table 1).  The history of these pets
revealed no gastrointestinal signs, and they were not examined further.
In order to determine the prevalence and density of gastric helicobacters as well as
gastric histology (Study III), 25 clinically healthy dogs, the health of which was verified by
history and further examinations, and 21 dogs with upper gastrointestinal signs were
obtained (Table 1).  One of these healthy dogs came from a pet shelter; the other healthy
dogs as well as all affected dogs were obtained from breeders.  Owners allowed the use of
their pets in this study.  Some of the dogs had undergone routine surgical procedures, e.g.,
ovariohysterectomy or castration.  All owners filled out a questionnaire to ensure that the
dogs had shown no gastrointestinal signs and that none had received medication during the
preceding month.  Dogs with only a few instances of pica (grass), borborygmus, and
flatulence were considered clinically normal and were included in the study.  For the dogs
with upper gastrointestinal signs, client-owned dogs were selected from among those that
had undergone an endoscopy procedure due to signs the cause of which had not been
obvious before endoscopy.  These 46 dogs had been given no nonsteroidal anti-
inflammatory agents, antibiotics, sucralphate, acid suppressants (e.g., cimetidine,
ranitidine, omeprazole), or any other medications for at least the 2 weeks prior to the study.
Clinical examination and the hematologic and biochemical analyses (Table 1) were
performed on all healthy and affected dogs, and abdominal radiography on affected dogs.
Dogs with metabolic diseases, gastrointestinal foreign bodies, and tumors were excluded.
Chronic intermittent vomiting, most often consisting of bile-stained fluid or mucus
and foam, was reported in 18 of 21 (86%) dogs with upper gastrointestinal signs.  Two of
the three dogs that did not vomit had signs of abdominal pain, borborygmus, flatulence,
and marked pica (grass), which were also reported commonly for the dogs which vomited;
the third dog had, in addition, bouts of abdominal bloating.  Duration of clinical signs
ranged from 1 month to 3 years (mean 8.5 months).
Nine dogs with upper gastrointestinal signs participated in the eradication therapy
follow-up study (IV) (Table 1).   Prior to the study, the pet owners had filled in a
questionnaire in which the nature and duration of the gastrointestinal signs, feeding habits,
environment, contacts with other animals, and previous medications were determined.
These dogs had suffered from upper gastrointestinal signs for 4 months to 4 years and had
been on medications such as antibiotics, sucralphate, cimetidine, or metoclopramide.
Obvious reasons for the gastrointestinal signs were ruled out, as in Study III, and also by
use of tests specific for intestinal disorders (Table 1); the criteria for patient exclusion were
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also the same.  Three dogs with mildly to moderately elevated alanine aminotransferase
(ALT) and alkaline phosphatase (ALP) concentrations were included in the study because
the suspected causes for their elevated liver enzymes was reactive hepatopathy due to the
gastrointestinal disorder and administration of glucocorticoids (Twedt 1998).  Complete
blood counts and biochemical analyses were repeated in follow-up controls.  ALP and ALP
levels normalized during the study when clinical signs had resolved, and when
corticosteroids were discontinued.
Table 1. The number, signalment and status of the animals in the studies.
Study Number and status of
animals
Sex, age and breed Selection criteria
I, II 10 dogs
Apparently healthy
10 cats
Apparently healthy
8 C; 2 B
1-13 yrs (mean 7.1 yrs)
6 different breeds
6 C; 4 B
1-17 yrs (mean 7.4 yrs)
Domestic shorthair
No GI signs.
No GI signs.
III 25 dogs
Clinically healthy
21 dogs
Affected
14 C, 1 (C); 10 B
1.5-8 yrs (mean 4.5 yrs)
11 different breeds
9 C, 3 (C); 9 B
1-11 yrs (mean 4.5 yrs)
16 different breeds
No GI signs.
No medication for 1  month.
No abnormalities in CBC, BP.
uGI signs without obvious reason.
No medication for 2 weeks.
No abnormalities in CBC, BP,
radiography.
IV 9 dogs
Affected
2 C, 1 (C); 6 B
1-5.5 yrs (mean 2.8 yrs)
9 different breeds
uGI signs without obvious reason.
Dietary hypersensitivity ruled out.
No abnormalities in CBC, BP,
radiography, serum folate and
cobalamine, fecal flotation for
parasites. 
V 2 dogs
Clinically healthy
8 dogs
Clinically healthy
2 C (dams)
1.5 and 2 yrs
Beagles
2 C; 6 B (puppies)
7 weeks
Beagles
No GI signs.
Helicobacter-negative after
eradication therapy.
No GI signs.
Helicobacter-negative before
experimental challenge.
(C) = neutered female
GI signs = gastrointestinal signs, i.e., nausea, vomiting, abdominal pain or discomfort, abdominal bloating, pica,
borborygmus, flatulence, constipation, diarrhea.
uGI signs = upper gastrointestinal signs, i.e., nausea, vomiting, abdominal pain or discomfort, abdominal bloating, pica.
CBC = complete blood count.
BP = biochemistry panel (sodium, potassium, calcium, alanine aminotransferase [ALT], alkaline phosphatase [ALP], urea,
creatinine, total proteins, albumin, cholesterol, glucose).
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The animals in the transmission study (V) were two conventional Beagle dams
acquired from a breeding unit producing experimental dogs, and their eight puppies, four
from each dam (Table 1). Pregnant dams (A and B) were acquired 3 weeks before the
expected delivery from an experimental dog-breeding unit. The dams were placed in a
separate unit for experimental animals of The Faculty of Veterinary Medicine where their
puppies were also kept.  The dams were found to be helicobacter-positive before delivery
and were therefore treated with eradication therapy, and checked 7 weeks later when they
were negative.  The negative helicobacter status of the puppies was verified before the
experimental challenge test.
7.2.Diagnostic methods
7.2.1. Comparison of diagnostic methods and topographic mapping (I-II)
The stomach was detached immediately after euthanasia by ligating it at the distal
esophagus and proximal duodenum; it was cut open along the greater curvature and rinsed
gently with tap water (37bC) to remove the contents.  The samples were collected from
three regions of the stomach: the fundus (including the cardia), the corpus, and the antrum
(including the pylorus).  A total of 17 samples were obtained from each dog, and 14 from
each cat. In dogs, there were four sample sites in the fundus, eight in the corpus, and five
in the antrum, and in cats four, six, and four, respectively (Figure 1).  The sample sites
were marked with sterile injection needles before sample collection, and instruments
sterilized with 2% glutaraldehyde were used to obtain each sample.  Mucus for brush
cytology and biopsy specimens for the urease test and histologic examination were
obtained from each sample site (Tables 2 and 3).  To identify Helicobacter species,
samples were also taken for TEM from three dogs and six cats, and for culture from eight
dogs and six cats from the fundus and corpus provided, that these regions had produced
positive result in the urease test. 
7.2.2. Endoscopy and biopsy procedures (III-V)
Before endoscopy, food was withheld from the dogs for 12 hours.  Endoscopy was
performed under general anesthesia (III-V).  Anesthesia was induced with intramuscular
(i.m.) or intravenous (i.v.) medetomidine 30-40 µg/kg followed by propofol 1-2 mg/kg i.v.,
and was maintained with halothane, or parenterally with propofol i.v. (0.5-1 mg/kg as
needed).  Puppies from 7 weeks to 3 months of age were anesthetized with fentanyl 0.002
mg/kg i.m. and medetomidine 20 µg/kg i.v. followed by propofol 1-2 mg/kg, from 3 to 6
months of age with medetomidine 40-50 µg/kg and ketamine 4 mg/kg i.m., and from 6
months of age forward as for the adult dogs. 
For endoscopy, the dogs were placed in left lateral recumbency.  A videoendoscope
with an outer diameter of 9.8 mm and biopsy channel diameter of  2.8 mm (Olympus EVIS
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GIF-100, Tokyo, Japan) was used for medium- and large-sized dogs, and a fiberoptic
endoscope with an outer diameter of 5 mm and biopsy channel diameter of 2 mm
(Olympus 
GIF-N30, Tokyo, Japan) for small dogs and puppies. Equipment and instruments were
cleaned thoroughly and sterilized in 2% glutaraldehyde for at least 20 minutes before use
(Henkel-Ecolab Disinfectant® or Henkel Hygiene GmbH, Düsseldorf, Germany; Cidex®,
Johnson & Johnson, Sollentuna, Sweden).  During endoscopy, the gastric mucosa was
evaluated for mucosal abnormalities. 
Figure 1.  Schematic drawings of anatomy of the canine and feline stomach, indicating gastric
regions and sample sites (numbers): Py = Pylorus (1-2), An = Antrum (3-5), Co = Corpus (6-13),
Fu = Fundus (14-15), and Ca = Cardia (16-17).  In cats, samples were not obtained from sites
number 5, 9, and 13 due to the smaller size of the stomach.  The stomach is opened along the
greater curvature.
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Mucosal biopsy specimens were obtained with biopsy forceps (Olympus FB-24Q or
FB-19K, Tokyo, Japan) for the urease test, histologic examination, TEM, and culture.
After taking mucus for brush cytology, biopsy specimens were collected mainly from the
corpus for the urease test, and then for culture and TEM.  Culture and TEM were
performed if the urease test gave a positive result.  For histologic examination, one or more
biopsies were always from the corpus and the others from the cardia, fundus, or antrum; in
most cases, all gastric regions were sampled.  The sampled gastric regions and number of
samples in various studies are detailed in Tables 2 and 3. 
7.2.3. Brush cytology (I-V)
For brush cytology, mucus was collected from the gastric mucosa with small, round
brushes (Interdental No. 3 Mini®; Jordan, Norway), a clean, disposable brush being used
on each sample site (I), or with an endoscopic cytology brush which was washed
thoroughly and disinfected after each use (hand wash: Cidex®, Johnson & Johnson,
Sollentuna, Sweden; machine wash: Henkel-Ecolab Disinfectant®, Henkel Hygiene
GmbH, Düsseldorf, Germany) (III-V).  The mucus was spread on a slide which was then
air dried and stained with May-Grünwald-Giemsa (MGG).  Helicobacters were sought in
each gastric mucus smear under a microscope at 400x (III-V) or 1000x (I-II) magnification
(Figure 2).  The sampled regions and criteria for recording results are detailed in Table 2.
In Studies I-II, the criteria for quantification were modified from McNulty et al (1989a).
7.2.4. Urease test (I-V) 
A modified rapid urease (MRU) test (Katelaris 1992) was used to demonstrate the
urease positivity of gastric biopsies.  Small mucosal specimens were cut with scissors from
the sample sites (I, II), or they were obtained with biopsy forceps (III-V).  Mucosal
specimens were placed immediately into the test reagent containing 10% unbuffered urea
in distilled water (pH 6.8) and 1% phenol red.  The Eppendorf tubes with 0.5 ml of test
reagent in each tube were stored in the freezer (>20bC) and warmed up to room
temperature before testing.  A color change from pale yellow to bright pink was considered
positive.  The test was incubated at room temperature for up to 24 hours, and the time of
a positive result was recorded (Table 2).
7.2.5. Histologic examination (I-IV)
The biopsy specimens for histologic examination were fixed immediately in 10%
buffered formalin, embedded in paraffin wax, sectioned (3-4 µm), and stained with
hematoxylin and eosin (HE).  Biopsy specimens negative for helicobacters with HE
staining were re-evaluated with Warthin-Starry staining (I, II), or with Giemsa staining
(IV).  Full- thickness specimens, which included all layers of the stomach wall, were
obtained with punch biopsy instruments (diameter 5-6 mm) from all the sample sites (I, II).
Endoscopic biopsy specimens were taken with biopsy forceps (for instruments, see section
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7.2.2.) (III-V).  Mucosal biopsies for histologic examination were collected from the
gastric regions as listed in Table 3 (I-V) and shown in Figure 1 (I, II).  The biopsy
specimens were collected together and then evaluated by one pathologist who was not
blinded to clinical or microbiological information.
Of the endoscopically obtained samples, only good-quality specimens were accepted
for histologic evaluation.  Each acceptable biopsy specimen was sufficiently large,
contained epithelium including glands and lamina propria, and showed only minimal
damage from crushing and stretching.  Histologic evaluation of each specimen included the
detection, colonization density, and location (mucosal surface including gastric pits, gastric
glands, and parietal cells) of helicobacters as well as the detection, number, and
distribution of inflammatory cells, i.e., mononuclear cells (lymphocytes and plasma cells),
neutrophils, and eosinophils.  The number of lymphocyte aggregates, i.e., accumulation of
lymphocytes regardless of size of accumulation or germinal center, in a specimen was also
counted.  Tissue changes, e.g., atrophy, dysplasia and metaplasia were evaluated.  Atrophy
was recorded when the gastric glands were atrophic and reduced in number and the mucosa
thinned, without evidence of active tissue destruction or regeneration.  Dysplasia was
recorded when epithelial lesions characterized by proliferating glandular elements irregular
in shape and size were evident.  Metaplasia was recorded when gastric epithelium appeared
to have an intestinal pattern or goblet cells were detected.  Ulcers as well as intraepithelial
inflammatory cells were also observed. 
Figure 2.  Photomicrograph of brush cytology specimen from corpus of a canine stomach,
demonstrating numerous helicobacters with distinctive spiral morphology.  May-Grünwald-Giemsa
stain; bar = 10 µm.
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Table 2.  Diagnostic methods for detecting gastric helicobacters, grading systems for the
bacteria, sampled gastric regions, and number of dogs tested (Studies I-V).
Method Study Sampled gastric
region (number of
samples dog/cat)
Number of animals tested Grading / recording system
Brush
cytology
I, II
III
IV
V
All regions 1)  
(Ca 2/2, Fu 2/2, Co
8/6, An 3/2, Py 2/2)
Corpus (1)
Corpus (1)
Corpus (1)
10/10 of each: apparently
healthy dogs & cats
24/25 clinically healthy dogs
11/21 dogs with upper GI signs
3/9 dogs at 1st visit
3/9 dogs at check-ups
4/4 dogs at long-term check-up
2/2 dams, 8/8 puppies
Scale: 0, 1, 2 2)
Scale: none, few, moderate,
many, numerous 3)
Result positive or negative
Result positive or negative
Urease
test
I, II
III
IV
V
All regions  
(Ca 2/2, Fu 2/2, Co
8/6, An 3/2, Py 2/2)
Corpus (1)
Corpus (1)
Corpus (1)
10/10 of each: apparently
healthy dogs & cats
25/25 clinically healthy dogs
21/21 dogs with upper GI signs
9/9 dogs at 1st visit
9/9 dogs at check-ups
4/4 dogs at long-term check-up
2/2 dams, 8/8 puppies
Positive results recorded at
30 & 60 min
Followed up to 24 h, times
for positive results recorded
Followed up to 24 h, times
for positive results recorded
Followed up to 24 h, times
for positive results recorded
TEM I, II
III
Fu (1), Co (1)
if urease-positive
Corpus (1)
if urease-positive
3/10 app. healthy dogs
6/10 app. healthy cats
22/25 clinically healthy dogs
5/21   dogs with upper GI signs
Morphologic features 4)
Morphologic features 4)
Culture I, II
III
V
Fu (1), Co (1)
if urease-positive
Corpus (1)
if urease-positive
Corpus (1)
if urease-positive
8/10 app. healthy dogs
6/10 app. healthy cats
25/25 clinically healthy dogs
6/21   dogs with upper GI signs
2/2 dams & 8/8 puppies
See text for details
1) Gastric regions: Ca = cardia, Fu = fundus, Co = corpus, An = antrum, Py = pylorus.
2) Predominant score of bacterial number based on evaluation of three representative fields after checking the whole specimen
(1000x): 0 = no helicobacters; 1 = occasional (1>10/field), not in all fields; 2 = numerous (>10/field).
3) Whole specimen evaluated (400x): none (0), few (1>10), moderate (10>30), many (30>50), numerous (>50).  
4) Large spiral bacteria without periplasmic fibrils having morphology resembling either that of H. bizzozeronii,  H. salomonis,
or non-fibrillated H. felis, or H. felis with periplasmic fibrils.
GI = gastrointestinal.
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Table 3.  Histologic evaluation of gastric biopsy specimens.
Study Gastric region sampled 1) and
number and status of animals
Grading system
I, II All gastric regions 2) 
10/10 of each: apparently
healthy dogs and cats
Number of lymphocyte aggregates per sample (200x): 
0, 1-2, 3
Number of neutrophils, eosinophils, lymphocytes & plasma
cells as the mean of three fields (400x):
0 = none, 1 = <10, 2 = 10-50, 3 = >50 
Helicobacter numbers (400x):
0 = none, 1 = 1-50 (few), 2 = >50 (numerous) 
Helicobacter location (400x):
0 = none, 1 = on mucosal surface and in gastric pits,
2 = 1 + in gastric glands, 3 = 1 + 2 + in parietal cells
III Corpus + 1-3 other regions 3) 
25/25 clinically healthy dogs
21/21 dogs with upper GI signs
VISUAL ANALOGUE SCALE:
Colonization density of helicobacters (400x): 
Mild = a few organisms on the mucosal surface ± single in
gastric glands or in parietal cells .
Moderate = several helicobacters on the mucosal surface ±
some in gastric glands and/or in parietal cells, or a few
helicobacters on mucosal surface + some in gastric glands
and/or in parietal cells.
Marked = several or numerous organisms on the mucosal
surface and several in gastric glands and/or parietal cells.
Number of mononuclear cells (/HPF): 
Normal = none or a few cells
Mild increase = several cells
Moderate increase = many cells
Marked increase = numerous cells
Number of neutrophils and eosinophils (/HPF): 
Normal = none or only single sporadic cells in a specimen
Mild = a few cells
Moderate = several cells
Marked = numerous cells
IV Corpus + 1-3 other regions 3) 
Dogs with upper GI signs:
9/9 dogs at 1st visit
9/9 dogs at check-ups
4/4 dogs at long-term check-up
VISUAL ANALOGUE SCALE (same as in Study III)
1) Gastric regions: cardia, fundus, corpus, antrum, pylorus.
2) Number of samples: cardia 2; fundus 2; corpus 8 (dogs) / 6 (cats); antrum 3 (dogs) / 2 (cats); pylorus 2.
3) Number of samples: A 1/ region.
HPF = high-power field, 400x magnification.
GI = gastrointestinal.
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 The animals, sample data, and  histologic evaluation are summarized in Table 3.  In
Studies I-II, the criteria for quantity of helicobacters and inflammatory variables were
modified from Handt et al (1994), and the results were also recorded according to Sydney
system nomenclature for human gastritis (Price 1991).  In Studies III-IV, colonization
density of helicobacters and number of inflammatory cells were evaluated by the visual
analogue scale (Dixon et al 1996) modified for canine gastric biopsy specimens and
expressed as the average of the whole specimen (Figure 3).  In these two studies, criteria
for normal gastric histology were: no cells to a few mononuclear cells per high-power field
(HPF; 400x magnification) and none to occasional scattered neutrophils and eosinophils
without tissue changes.  Sparse lymphocyte aggregates without an increase in inflammatory
cells were considered normal.  Chronic gastritis was diagnosed if the number of
mononuclear cells was increased and was graded as mild, moderate, or severe (Figure 4).
Increased number of neutrophils indicated active gastritis which was also graded as mild,
moderate, or severe (II).  Gastritis was diagnosed as regional if it did not appear in all
gastric regions, and as focal if it was not diagnosed in all biopsy specimens from one
particular gastric region.  The terms ”superficial” and ”diffuse” were used to describe the
distribution of inflammatory cells in the gastric mucosa. 
Figure 3.  Schematic visual analogue scale for evaluating and grading helicobacter organisms
and inflammatory cells in canine gastric biopsy specimens.  Each feature is observed and
recorded by matching its appearance with the grading panel.  When considerable variation in
intensity is evident in the same biopsy specimen, the mean for several areas is determined and
the specimen scored accordingly. Broken vertical lines in the top panel indicate two methods for
grading mild, moderate, or marked colonization density.
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Figure 4.  Photomicrographs of canine biopsy specimens obtained from the corpus of the
stomach showing (a) normal gastric histology, and (b) mild, (c) moderate, and (d) severe chronic
gastritis. HE stain; bar = 100 µm.
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7.2.6. Transmission electron microscopy (I-III)
Samples for TEM were trimmed into about 1 mm3 pieces, fixed for 2 h in 2.5%
glutaraldehyde in 0.1M Sörensen phosphate buffer (pH 7.3), and stored in the buffer.  The
samples were post-fixed in 1% osmium tetroxide, dehydrated in acetone, embedded in
epoxy resin (Epon LX 112; Ladd, USA), and polymerized.  Ultrathin sections (0.06 µm)
were placed on grids, stained with uranyl acetate and lead citrate, and examined with a
JEM 100 S transmission electron microscope (Jeol, Tokyo, Japan).  Helicobacter species
were determined by TEM according to their morphological features: size of the bacterium,
number of coils, and presence or absence of periplasmic fibrils (Weber and Schmittdiel
1962, Lockard and Boler 1970, Lee et al 1988, Solnick et al 1993).  Evaluated samples and
rough identification of Helicobacter species are presented in Table 2 and Figure 5.
Figure 5.  Transmission electron micrographs of canine gastric mucosa revealing typical
morphologic features of (a) Helicobacter bizzozeronii, (b) H. felis with periplasmic fibrils around
the cell body (arrow), and (c) cultured H. salomonis, as well as (d) mixed infection with H.
bizzozeronii (Hb) and H. felis (Hf).  Uranyl acetate & lead citrate stain (a, b, d), negative stain (c);
bar = 2 µm.
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7.2.7. Culture (I-III, V)
Biopsy specimens were obtained from the corpus and fundus (I, II) or only from the
corpus (III, V) if a positive urease test result was obtained from these regions.  The
specimens were placed in a transport medium (Portagerm Pylori®, bioMérieux sa, Marcy
l’Etoille, France) and cultured within 1 to 24 (I-II) or 2 to 8 (III, V) hours after sampling.
Specimens were swabbed on fresh BHI blood agar or brucella blood agar containing
selective antibiotics (trimethoprim 2.5-5 µg/ml, vancomycin 5-10 µg/ml, polymyxin-B
1.25 IU/ml, and cycloheximide 50 µg/ml or amphotericin B 2 µg/ml), or alternatively,
specimens were crushed and placed in 300 to 500 µl of BHI broth containing 7% horse
serum, and the preparation was spread on BHI blood agar plates containing the selective
antibiotics.  Plates 
were incubated at 37bC microaerobically (5% O2, 10% CO2 and 85% N2) up to 10 days.
Growth was usually visible as a spreading film after 3 to 10 days.  Preliminary
identification of Helicobacter spp. was made on the basis of morphologic characteristics
determined from examination of gram-stained slides and a positive result on the urease
test.  Additional identification was performed by use of TEM, phenotyping tests, and
DNA-DNA hybridization analysis.  Bacterial culture and characterization of cultures have
been described in detail earlier (Paster et al 1991, Hänninen et al 1996, Jalava et al 1997).
The isolates were stored in sterile skim milk with 15% glycerol at -70°C for later studies.
Cultured biopsy specimens are listed in Table 2.
The fecal samples were studied for fecal excretion of helicobacters (V) by filtration
of the fecal extract through a membrane filter with a pore size of 0.45-0.65 mm (Steele and
McDermott 1984) or by inoculating fecal material on BHI blood agar with antibiotics.
This fecal study was performed on the dams before the antimicrobial treatment and on the
puppies after the last challenge with H. bizzozeronii and 3 months later.
7.2.8. Genotyping (V)
Restriction fragment analysis (REA) and ribotyping were used to study
similarities of the isolates from dams and from puppies.  Chromosomal DNA was isolated
and purified by the guanidium thiocyanate method (Pitcher et al 1989).  The concentration
and purity of DNA was determined spectrophotometrically (Popovich et al 1993).  The
DNA (5 µg) was digested with the restriction enzymes HaeIII, PstI, and ClaI according to
the recommendations of the manufacturer (New England Biolabs, Hertfordshire, UK).  The
digested DNA was electrophoresed at 25 V for 16 h in horizontal (0.8% w/vol) agarose in
buffer (40 mM/l Tris-acetate and 2 mM/l EDTA).  After electrophoresis, the gels were
stained in ethidium bromide (1 µg/ml) and photographed.  After photography, the gels
were transferred by vacuum transfer (Vacu Gene XL, Pharmacia-LKB, Uppsala, Sweden)
to MSI nylon membrane (MSI, Westboro, MA, USA).  The probe, prepared from 16S
+23S RNA of Escherichia coli by reverse transcriptase (Boehringer Mannheim, Germany),
was labeled with digoxigenin.  The samples were prehybridized at 58°C for 3 h and
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hybridized at 58°C for 18 h (Popovich et al 1993).  The hybridization products were
visualized colorimetrically with antidigoxigenin-alkaline phosphatase (Boehringer
Mannheim).  Two unrelated H. bizzozeronii stains were included in the studies. 
For further comparison of the isolates, pulsed-field gel electrophoresis (PFGE)
analysis was performed.  The isolates were grown on BHI blood-agar for 3 days at 37°C
in a microaerobic atmosphere.  The bacterial cells were harvested and treated with
formaldehyde to inactivate endogeneous nucleases (Gibson et al 1994).  Otherwise, DNA
was prepared by the method of Maslow et al (1993).  The bacteria were embedded in 1%
low-melting agarose plugs (SeaPlaque GTG, FMC Bioproducts, Rockland, ME, USA).
The plugs were washed and stored at 4°C in Tris-EDTA buffer, pH 7.5.  Two-mm slices
of the agar plugs were digested with NotI and SpeI (New England Biolabs). The DNA
fragments were separated with Gene Navigator (Pharmacia LKB Biotechnology AB,
Uppsala, Sweden) in 1% agarose gel in 0.5 X TBE (45 mM Tris, 45 mM boric acid, 1 mM
EDTA) at 200 V.  NotI fragments were separated  with a ramped pulse from 4 to 80 sec for
22 h and SpeI fragments were separated with a stepping program (0.5 sec/1 h, 0.7 sec/1 h,
0.9 sec/1 h, 2 sec/3 h, 4 sec/4 h, and 6 sec/4 h).
7.2.9. Metronidazole sensitivity testing (V)
Sensitivity to metronidazole was tested by adding 5, 10, or 15 mg/l of metronidazole
(Sigma, St. Louis, MO, USA) into BHI blood-agar medium (Rautelin et al 1992) and
spreading H. bizzozeronii culture on the plates.  The medium without metronidazole served
as the control medium.  All plates were incubated microaerobically for up to 7 days.   If no
growth occurred, the isolate was regarded as sensitive.
7.3.Eradication therapy and follow-up study (IV)
 
Endoscopy was performed at entry and repeated one to three times during the follow-
up period ranging from 1 to 12 months (mean 5.5).  Control endoscopies were performed
within 12 weeks (mean 3) after eradication therapies and within 3.5 months (mean 1.5)
after additional therapies.  In addition, four of the dogs that became helicobacter-negative
after eradication therapies were reevaluated 1.5 to 3 years (mean 2.5) later. 
At entry to the study, dogs with dietary hypersensitivity were excluded.  Triple
therapy, used for the eradication of human H. pylori (Tytgat 1994), consisted of orally
administered  amoxicillin 20 mg/kg and  metronidazole 10 mg/kg twice a day for 10 to 14
days, as well as bismuth subcitrate 6 mg/kg twice a day for 2 to 4 weeks.  If gastric
helicobacters persisted after triple therapy, alternative eradication therapy with tetracycline
20 mg/kg twice daily and omeprazole 0.7 mg/kg once a day was administered orally for 10
and 14 days, respectively.  If the clinical signs still persisted after eradication of
helicobacters, additional therapies such as tylosin, sucralfate, cimetidine, prednisolone, and
cisapride were prescribed individually.  The owners maintained a detailed standardized
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follow-up diary recording clinical signs daily during each treatment protocol for evaluation
of gastrointestinal signs.  In the reexaminations, hematological and biochemical analyses,
abdominal radiographs, and endoscopy were repeated, and helicobacter-status and gastric
histology were verified.
7.4.Transmission study (V)
At their arrival, the pregnant dams were verified as helicobacter-positive, and
subsequently, were treated before delivery with triple therapy similarly to that of Study IV,
but amoxicillin, metronidazole, and  bismuth subcitrate were administered twice a day for
10 days.  Seven weeks after cessation of the antimicrobial treatment, the biopsy samples
of the dams were negative in the urease test, and no spiral organisms appeared in brush
cytology of mucus specimens.  The dams nursed the puppies for 7 weeks in separate
isolated rooms, and after weaning the dams were transferred to another unit for
experimental dogs of the Faculty of Veterinary Medicine.  New biopsy samples were
obtained from the dams 5 months after treatment and once again 2 years later. 
The puppies were verified as helicobacter-negative after weaning, at 7 weeks of age.
Eight puppies were divided into two groups, each of which consisted of two puppies from
dam A and two from dam B.  Three puppies in the first group were orally challenged with
a suspension of 108 CFU (colony-forming units) of H. bizzozeronii CCUG 35045 in 2 ml
of brucella broth daily for 2 consecutive days; the fourth puppy was left exposed to
infection.  The puppies of  the second group served as non-challenged controls.  Biopsy
samples from the puppies were taken before the inoculation, and 2 weeks, 3 months, and
7 months after the challenge.  The puppies were raised in separate rooms located on
different floors with strict hygienic control to prevent transmission of infection.
7.5.Statistical analyses
Cochran's Q-test was used to compare differences between gastric regions in the
occurrence of helicobacters and in active as well as in chronic gastritis (I), and when
gastric regions were compared for differences between the results produced by brush
cytology, the urease test, and histologic examination (II).  Friedman two-way analysis of
variance was used to analyze whether any differences existed between different gastric
regions in the number of inflammatory cells and in the location of helicobacters (I).  The
Kruskal-Wallis one-way analysis of variance was used to test among groups with
various numbers of helicobacters whether any differences existed in the number of
inflammatory cells and the location of helicobacters (II).  The groups were classified as
cats with none, few, or numerous helicobacters and as dogs with few or numerous
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helicobacters.  The Fisher exact test for 2 x 2 tables served to determine the statistical
association between occurrence of helicobacters and active or chronic gastritis (II).
Differences in prevalence and density of helicobacters and in gastric inflammatory
parameters between clinically healthy dogs and dogs with signs of gastritis, as well as
between dogs with a single and a mixed Helicobacter species infection, were tested by the
two sample proportion test and Mann-Whitney test (III).  Cochran’s Q-test, Friedman
two-way analysis of variance, and the Wilcoxon signed rank test were used to examine
differences between gastric regions (III).  The association between colonization density of
helicobacters and gastric inflammatory parameters was studied by the Spearman rank
correlation coefficient (rS) (III).  If several biopsies were obtained from one particular
gastric region, that with the most pronounced finding was used for statistical analysis.
The sign test was used to analyze whether any changes existed in clinical signs and
in gastric histology after triple therapy and after additional therapy (IV).  The Mann-
Whitney test was used to study the differences in upper gastrointestinal signs between
helicobacter-positive and helicobacter-negative dogs.
P-values < 0.05 were considered significant.
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8. RESULTS
8.1.Comparison of diagnostic methods for detecting gastric
helicobacters (I, III)
Results of individual diagnostic methods are presented in Table 4.  Brush cytology
was the best method for detecting gastric helicobacters.  A few to numerous helicobacters,
most often many, were demonstrated by brush cytology.  The urease test and histologic
examination (HE staining) were also good methods, because only in the antrum did they
produce more negative results than did brush cytology.  In most cases, the results from
brush cytology, the urease test, and histology were concordant.  In 5/44 cases, brush
cytology was the only method showing helicobacters (III, IV).  The urease test was positive
generally after 15-30 minutes; none of the positive results being recorded at 24 hours.
Warthin-Starry staining revealed helicobacters in one of the canine samples in which HE
staining had failed to demonstrate them (I).  When the urease test and histologic
examination were both negative, the number of helicobacters detected by brush cytology
was usually low.  However, in seven clinically healthy dogs and in one affected dog, only
a few helicobacters were detected by brush cytology, although their urease tests rapidly
became positive, and in histology several or numerous helicobacters were visible (III).  
TEM also revealed  helicobacters in the majority of cases.  Culture, however, was not as
rewarding as these methods, although culture was more successful in dogs than in cats.
Four of the ten cats were helicobacter-negative by brush cytology, the urease test, and
histologic examination.
When gastric regions were compared in dogs, significant differences between the
results produced by brush cytology, the urease test, and histologic examination were
detected (I).  These differences were most evident in the antrum, where the urease test gave
a positive result in only 62% and histologic examination in 74% of the samples, whereas
brush cytology results were positive in 100% of the samples (Table 4).  In cats, no
differences between the three diagnostic methods were found in any gastric region.
When the sensitivity and specificity of the methods were tested, the urease test and
histologic examination were each compared with brush cytology, which was invariably
capable of detecting the presence of gastric helicobacters (I).  The sensitivity of the urease
test at 30 and 60 min was 85.7% and 87.5% in dogs, and 94% and 100% in cats,
respectively, and the specificity was 100% in both dogs and cats.  The sensitivity of the
histological examination was 92.3% in dogs and 97.6% in cats, and the specificity 100%
in both species.
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Table 4. Percentages of helicobacter-positive samples obtained by different diagnostic
methods in positive animals, i.e., those positive by at least one method, in various gastric
regions (number of animals in parentheses).
Method Apparently healthy
cats (I)
Apparently healthy dogs
(I)
Clinically healthy
dogs (III)
Dogs with upper
GI signs (III)
Brush
cytology
Co 100% 
Fu 100%
An 100%
14 sites/animal
(n = 6)
Co 100% 
Fu 100%
An 100%
17 sites/animal
(n = 10)
Co 100% 
1 site/animal
(n = 25) 
 Co 100% 
 
1 site/animal
(n = 20)
Urease test Co  100%  (30 min) 
Fu  88%    (30 min)
      100%  (60 min)
An  92%    (30 min)
      100 % (60 min)
14 sites/animal
(n = 6)
Co  96%   (30 min) 
      100%  (60 min)
Fu  95% (30 & 60 min)
An  62% (30 & 60 min)a)
17 sites/animal
(n = 10)
Co 96% 
      (15-30 min)
 
1 site/animal
(n = 25)
Co 90% 
      (15-30 min)
1 site/animal
 (n = 20)
Histologic
examination
(HE)
Co  100%
Fu  100%
An  92%
14 sites/animal
(n = 6)
Co  100%
Fu  100%
An  74% b), c)
17 sites/animal
(n = 10)
96% 
All regions
combined
(n = 25)
90%
All regions
combined
(n = 20)
TEM Fu+Co 100% 
1 site/region/animal
(n = 6)
Fu+Co 100%  
1 site/region/animal
(n = 3)
Co 91%  
1 site/animal
(n = 22)
Co 100% 
1 site/animal
(n = 5)
Culture Fu+Co 17% 
1 site/region/animal
(n = 6) 
Fu+Co 37% 
1 sample site/region
(n = 8)
Co 40% 
1 site/animal
(n = 25)
Co 50% 
1 site/animal
(n = 6) 
GI = gastrointestinal.
Co = corpus, Fu = fundus (including cardia), An = antrum (including pylorus).
HE = hematoxylin and eosin staining.
TEM = transmission electron microscopy.
Significant differences between results produced by various diagnostic methods:
a) Urease test compared to to brush cytology (P < 0.001).
b) Histologic examination compared to urease test at 30 and 60 minutes (P < 0.05).
c) Histologic examination compared to brush cytology (P < 0.001).
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8.2.Prevalence (II, III) and colonization density (III)
An animal was considered helicobacter-positive when any one test produced a
positive result.  All of the ten apparently healthy dogs (II) and 25 clinically healthy dogs
(III) were helicobacter-positive (100%), and gastric helicobacters were also detected in 20
of 21 (95%) affected dogs (III).   Of the ten apparently healthy cats, six were positive
(60%) (II).  Helicobacters were found both in young and in old animals and in both males
and females. Gastric helicobacters were more common in clinically healthy dogs than in
dogs with upper gastrointestinal signs in all gastric regions, but without statistically
significant differences (III). 
Nor were significant differences detected in the colonization density of helicobacters
in any gastric region between clinically healthy and affected dogs (III).  Age of dog was not
associated with colonization density.  When helicobacters were present, histologic
examination most often revealed moderate to marked colonization density in both groups
of dogs.  Mild colonization density was detected in only one healthy dog and in two
affected dogs, and their urease tests yielded positive results within 30 to 45 minutes.  Brush
cytology showed many helicobacters in the healthy dog but was not performed on the two
affected dogs.
8.3.Topography of gastric helicobacters (II, III)
Gastric helicobacters were detected thoroughout the stomach.  However, significant
differences existed in helicobacter prevalence between gastric regions in dogs, and
helicobacters were found less frequently in the antrum than in other regions (Study II
P<0.01; Study III P<0.05).  A significant difference (P<0.001) existed also in colonization
density of helicobacters between different gastric regions in clinically healthy and affected
dogs, with the lowest number of helicobacters detected in the antrum (III).  In positive cats,
helicobacters occurred in every gastric region without differences between regions. 
Helicobacters were detected superficially on the mucosal surface and in gastric pits,
and deeper in gastric glands and in parietal cells both in dogs and in cats.  In Study II, the
location of the organisms was significantly (P<0.05) more superficial in the antrum than
in the fundus and corpus in dogs but not in cats.  Helicobacters were located significantly
(P<0.01) deeper in the corpus in cats with histologically verified chronic gastritis than in
those without.
8.4.Association of helicobacters with gastric inflammation
A total of 309 gastric biopsy specimens were obtained endoscopically for histologic
examination in Studies III and IV.  Of these samples, 17% (52/309) were rejected because
of non-diagnostic quality.  From the antrum, 49% (33/67) were non-diagnostic, from the
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cardia ,13% (9/69), from the fundus, 6% (4/64), and from the corpus, 6% (6/109).
Therefore, the majority of non-diagnostic samples, 33/52 (63%), were from the antrum,
and the best quality specimens were obtained from the corpus and fundus. 
8.4.1. Gastric helicobacters and inflammatory parameters (II, III)
In apparently healthy dogs, significant associations did not exist between number of
helicobacters (few versus numerous) and any inflammatory cell type (II).  Colonization
density of helicobacters was not positively associated with number of gastric inflammatory
parameters in any gastric region either in clinically healthy dogs or in dogs with upper
gastrointestinal signs (III).  Among affected dogs, colonization density was negatively
correlated with the number of mononuclear cells in the cardia and body and with the
neutrophils in the cardia (P<0.05).  Similar negative correlations were evident also among
clinically healthy dogs, but these were not significant.  When these two group of dogs were
combined, negative correlations still remained (P<0.05).
Lymphocytes, plasma cells and lymphocyte aggregates were present in the stomachs
of all dogs, with neutrophils and eosinophils seen less frequently.  Study II showed no
statistically significant difference in the number of neutrophils, eosinophils, lymphocytes,
or lymphocyte aggregates between gastric regions, i.e., the fundus (including cardia),
corpus, and antrum (including pylorus), but significantly more (P<0.05) plasma cells were
found in the antrum than in the corpus.  In Study III, mononuclear cells and neutrophils
were relatively evenly distributed throughout the stomach in clinically healthy dogs and in
dogs with upper gastrointestinal signs without any significant differences between gastric
regions, whereas the number of lymphocyte aggregates was greatest in the fundus of
healthy dogs and in the corpus of affected dogs (P<0.05).  Eosinophils in affected dogs
were fewest in the corpus (P<0.05). 
  The prevalence of lymphocyte aggregates, mononuclear cells, neutrophils, and
eosinophils between clinically healthy dogs and dogs with upper gastrointestinal signs
differed significantly (P<0.05) (III).  In affected dogs, lymphocyte aggregates were detected
more often in the corpus, mononuclear cells in the cardia and antrum, and eosinophils in
the cardia.  Minor differences were evident in the density of inflammatory parameters
between healthy and affected dogs among gastric regions, but these were not significant.
Helicobacter-positive cats with numerous helicobacters demonstrated significantly
more lymphocytes in the fundus and corpus than did helicobacter-negative cats (P<0.05)
(II).  Lymphocytes and plasma cells were present in the stomach of all ten apparently
healthy cats.  Plasma cells were significantly more (P<0.05) in the antrum than in the
corpus of positive cats, but in helicobacter-negative cats they were seen only in the antrum.
Lymphocyte aggregates were seen only in helicobacter-positive cats, and in at least one
region.  Neutrophils were found in five positive and four negative cats in at least one
region, most commonly in the antrum.  Three positive cats had eosinophils in the fundus.
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8.4.2. Helicobacters and gastritis
Gastric histologic diagnoses in Studies II-IV are summarized in Table 5.  For the first
set of histologic criteria, mild chronic gastritis in the fundus, corpus, and antrum was
recorded in all ten apparently healthy dogs, with no statistically significant difference in
occurrence of chronic or active gastritis between gastric regions (II).  In conjunction with
chronic gastritis, mild active gastritis was seen in six dogs in one, two, or all three regions.
No statistically significant association between active gastritis and the number of
helicobacters (few or numerous) appeared.
All apparently healthy cats had mild chronic gastritis in the antrum whether or not
helicobacters were present; chronicity was accompanied by activity in four positive cats
and all negative cats (II).  Both chronic and active gastritis were seen significantly
(P<0.01) more often in the feline antrum than in other regions.  A significant (P<0.05)
association between the presence of helicobacters and chronic gastritis was found in the
corpus and fundus.  In contrast, no significant association existed in cats between
helicobacters and active gastritis.
The criteria of the visual analogue scale revealed normal gastric histology in all
gastric regions significantly (P<0.05) more often in clinically healthy dogs (13/25, 52%)
than in dogs with upper gastrointestinal signs (4/21, 19%) (III).  Two affected dogs had
mild scattered eosinophilic infiltration alone, and the histologic diagnosis for the remaining
dogs was most commonly mild to moderate gastritis, with or without scattered neutrophilic
or eosinophilic infiltrates, or both. Chronic gastritis in these dogs was most often regional
and superficial.  Active gastritis was detected most often in association with moderate or
severe chronic gastritis.  Severe chronic gastritis was diagnosed in one healthy and in two
affected dogs, and it was classified as regional and diffuse.  Colonization density of
helicobacters in these two affected dogs was only mild, whereas in the healthy dog it was
moderate. 
In Study IV, the most common initial histologic diagnosis was also mild chronic
gastritis, detected initially in six of nine dogs.  Mild eosinophilic activity in addition was
found in three of these dogs, and eosinophilic activity alone was present in two. One dog
had normal gastric histology.  The degree of chronic gastritis in different regions among
clinically healthy dogs and cats and among dogs with upper gastrointestinal signs is
presented in Figure 6.
Gastric ulcers or erosions, macroscopic or microscopic, were detected in no dog or
cat.  Mild to moderate atrophy, dysplastic epithelial changes, or metaplasia were diagnosed
in only a few clinically healthy and affected dogs (III).  These changes were always
associated with chronic gastritis and were most common in conjunction with moderate to
severe gastritis.  Similar changes were not found in apparently healthy dogs or cats (II).  
Except for parietal cells, helicobacters were not seen in other glandular cells or in
epithelial cells.  In the presence of helicobacters, the appearance of parietal cells varied
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from normal to vacuolated.  When helicobacters were demonstrated in parietal cells by
TEM, they appeared mainly in dilated intracellular canaliculi.
Table 5. Gastric histologic diagnoses in various groups of animals in Studies II-IV classified
separately for the antrum and body of the stomach.
Histologic
diagnosis
Apparently
healthy cats (II):
Hb-neg (n=4) /
Hb-pos (n=6)
Apparently
healthy
dogs (II):
All Hb-pos
(n=10)
Clinically
healthy
dogs (III):
All Hb-pos
(n=25)
Dogs with
signs of
gastritis (III):
All Hb-pos
(n=21)
Dogs with upper
gastrointestinal
signs; Hb-pos (IV):
Pre-ther (n=9) /
Post-ther Hb-neg
(n=8)1)
Any abnormality 4/6 (100/100%) 10 (100%) 12 (48%) 17 (81%) 8/8 (89/100%)
ANTRUM 2)
Normal
Chronic gastritis
+ Active gastritis
Eosinophils 
    (± gastritis)
0/0  (0/0%)
4/6  (100/100%)
4/4  (100/67%)
0/0  (0/0%)
  0 (0%)
10 (100%)
  4 (40%)
  4 (40%)
(n1=13)
9  (69%)
4  (31%)
2  (15%)
2  (15%)
(n1=14)
  3  (21%)
11  (79%)
  4  (29%)
  5  (36%)
(n1=4/7)
2/2  (50/29%)
1/1  (25/14%)
0/1  (0/14%)
2/3  (50/43%)
BODY 3)
Normal
Chronic gastritis
+ Active gastritis
Eosinophils 
    (± gastritis)
4/0  (100/0%)
0/6  (0/100%)
0/2  (0/33%)
0/0  (0/0%)
  0 (0%)
10 (100%)
  5 (50%)
  7 (70%)
13  (52%)
12  (48%)
  4  (16%) 
  4  (16%)
  6  (29%)
13  (62%)
  4  (19%)
  7  (33%)
2/3  (22/38%)
5/4  (56/50%)
1/0  (11/0%)
4/2  (44/25%)
Hb-neg = helicobacter-negative; Hb-pos = helicobacter-positive.
Pre-ther = before eradication therapy; Post-ther= after eradication therapy; eradication therapy = amoxicillin, metronidazole,
and bismuth subcitrate., or tetracycline and omeprazole after failed triple therapy in one case.
n1= number of sampled animals if not the same as the total number of animals in various groups.
1) One dog remained helicobacter-positive after eradication therapy, and had a small number of eosinophils in the gastric
body; the antrum sample was non-diagnostic.
2) Antrum includes pylorus.
3) Body includes corpus, fundus, and cardia.
8.5.Number of Helicobacter species and gastric inflammation (III)
Presumptive identification by use of TEM revealed one or two Helicobacter species.
No H. felis occurred in any TEM specimen from cats but was cultured on one occasion.
Helicobacter species identified by use of culture were H. bizzozeronii,  H. felis, H.
salomonis, and mixed-culture (Table 6).  In the case of the mixed culture of H. salomonis
and H. felis, TEM revealed only large spiral organisms.  Culture usually identified only one
of the two Helicobacter species seen during TEM of the specimen.  When large spiral
Helicobacter organisms were detected by TEM, alone or with H. felis, the most common
species isolated by culture was H. bizzozeronii.
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The number (one or several) of Helicobacter species had no statistically significant
effect on number of lymphocyte aggregates, mononuclear cells, neutrophils, or eosinophils
either in clinically healthy dogs or in dogs with signs of gastritis.  Neither was there
significant effect when these two group of dogs were combined.
Figure 6.  Degree of chronic gastritis in various gastric regions in clinically healthy dogs, in dogs
with upper gastrointestinal signs, and in clinically healthy cats, expressed as percentages. Both
helicobacter-positive and helicobacter-negative animals are included.
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Table 6.  Number of animals with different Helicobacter species identified by transmission
electron microscopy (TEM) and culture in different animal groups in Studies II and III.
Method Helicobacter
species
Apparently
healthy cats
Apparently
healthy dogs
Clinically
healthy dogs
Dogs with upper
gastrointestinal
signs
TEM Large spiral non-
fibrillated bacteria
only 1)
6 2 10 3
Fibrillated H. felis
only
0 0 0 0
Mixed 2)
Not detected
0
0
(n=6)
1
0
(n=3)
10
2
(n= 22)
2
0
(n=5)
Culture H. bizzozeronii 0 2 6 2
H. felis 1 1 1 1
H. salomonis 0 0 2 0
Mixed 3)
Not isolated
0
4
(n=6)
0
5
(n=8)
1
15
(n=25)
0
3
(n=6)
1) Morphology resembling that of H. bizzozeronii, H. salomonis, or non-fibrillated H. felis.
2) Large spiral bacteria and fibrillated H. felis.
3) H. salomonis and H. felis.
8.6.Effect of eradication therapy on gastric helicobacters,
clinical signs and gastric histology (IV)
At study entry, all nine dogs with upper gastrointestinal signs were positive for
gastric helicobacters, and with triple therapy, seven became negative.  One dog remained
positive after triple therapy but became negative after treatment with tetracycline and
omeprazole.  One dog was initially considered to be helicobacter-negative after triple
therapy according to HE-stained histologic specimens, but was subsequently found to be
positive by Giemsa staining; therefore, the alternative therapy with tetracycline and
omeprazole for eradicating helicobacters was not instituted, and instead additional therapy
was prescribed.
As for upper gastrointestinal signs, with eradication therapy these were alleviated
significantly (P<0.05); with additional therapies (tylosin, sucralfate, cimetidine,
prednisolone, or cisapride), clinical signs were alleviated significantly further (P<0.01)
(Table 7).  With triple therapy, clinical signs were alleviated clearly or slightly in 7/9 dogs,
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78% (SE 13.9%), and with additional therapy, the upper gastrointestinal signs resolved
totally in 7/8 dogs, 88% (SE 11.7%).  Changes in clinical signs after triple therapy between
dogs remaining helicobacter-positive (n=2) and helicobacter-negative dogs(n=7) did not
differ significantly.
In gastric histology, no significant change was evident after triple therapy (Table 7).
Mild chronic gastritis persisted after triple therapy in 3/6 dogs.  In the three other dogs,
additional eosinophilic activity disappeared, whereas chronic gastritis persisted in one dog
but resolved in the other two.  In two dogs showing eosinophilic activity alone on initial
examination, eosinophilic activity persisted in one and disappeared in the other.  One dog
had initially normal histology but developed mild eosinophilic activity during the follow-
up period.  No significant changes were detected in gastric histology between the first visit
and after additional therapy or between the first visit and after long-term follow-up. 
Table 7.  Changes in clinical signs and gastric histology after triple therapy and additional
therapies shown as number of dogs per number of examined dogs.
Change After  triple therapy After  additional therapies
Clinical signs 1) Gastric histology Clinical signs when
compared to those after
triple therapy 2)
Gastric histology
Improved 3) 7 / 9 2 / 9 8 / 8 3 / 5
Unchanged 2 / 9 6 / 9 0 / 8 1 / 5
Worsened 0 / 9 1 / 9 0 / 8 1 / 5
1)Significant alleviation after triple therapy (P<0.05).
2)Significant alleviation after additional therapy (P<0.01).
3)In gastric histology, improved refers to decrease in any inflammatory cell type.
8.7.Recurrence of gastric helicobacters after eradication (IV)
In the eight dogs that became helicobacter-negative after eradication therapies,
gastric  helicobacters remained absent at the end of the first follow-up period, i.e., up to 7.5
months.  In four of these dogs, the helicobacter status was verified only once after therapy,
within 0.5 to 3 months.  In all four dogs at the long-term follow-up, helicobacters had
recurred, but these dogs showed none or only occasional mild upper gastrointestinal signs
that were controlled with diets or short-term medication.  In two long-term follow-up dogs,
helicobacter status was considered “likely positive”, as organisms were detected only in
brush cytology and were  few in number with morphology too indistinct to allow reliable
identification.
53
8.8.Transmission of gastric helicobacters (V)
Large, spiral urease-positive organisms, later identified as H. salomonis, were
isolated from the biopsy sample taken from dam B (isolate BI) before her eradication
therapy. Although the biopsy sample from dam A was positive in the urease test, and large
spiral organisms were visible in the brush cytology mucus specimen, bacterial culture was
unsuccessful.  Seven weeks after cessation of treatment, at the end of the lactation period,
the biopsy samples from the dams were urease-negative, and helicobacters were no longer
detected by brush cytology.  Three and a half months after the weaning, H. salomonis was
isolated from both dams (isolates AI and BII).  Two years later, H. salomonis was isolated
from dam B but not from dam A. 
The urease tests and brush cytology specimens were positive in all four challenged-
group puppies, and the inoculated strain of H. bizzozeronii (CCUG 35045) was isolated 2
weeks and 3 and 7 months after the challenge. The biopsy samples from three puppies of
the non-challenged group were unexpectedly urease-positive 2 months after the beginning
of the experiment.  Spiral organisms were isolated from three non-challenged puppies after
3 months from the beginning of the challenge and then during the entire sampling period.
No helicobacters were isolated from the fecal samples of the dams or the puppies at any
stage.
REA of chromosomal DNA of the isolates, digested either with HaeIII or PstI,
revealed that all isolates from dam B and from the non-challenged puppies were highly
similar, but differed from the patterns of two non-associated H. bizzozeronii strains and
from those of H. bizzozeronii CCUG 35045.  The patterns of dam A had some banding
differences from those of dam B and the puppies.  Ribopatterns of Helicobacter isolates
from both dams and from the non-challenged puppies were all identical.  For one puppy,
banding patterns of two isolates originating from different sampling periods were identical.
Non-associated H. bizzozeronii strains produced different banding patterns.  In PFGE
analysis, SpeI patterns of the isolates of both the dam B and the non-challenged puppies
were identical, but the pattern of dam A differed by two fragments.  Furthermore, NotI
pattern analysis revealed that the isolate of dam A clearly differed from the isolates of dam
B and those of non-challenged puppies, indicating that helicobacters of the puppies
originated from dam B.
H. bizzozeronii CCUG 35045 and the isolates from challenged puppies were
sensitive to metronidazole.  The isolates from the dams and non-challenged group were
metronidazole-resistant (MIC >15 mg/l with a agar dilution method), which may explain
the failure of triple therapy to eradicate helicobacters of dam B, and subsequently, the
transmission of helicobacters to her puppies.
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9. DISCUSSION
The pet animals of the studies were carefully selected to fulfill strict criteria such as
the depth and completeness of the clinical background and medication data.  Although the
number of animals remained quite small, it enabled a thorough and detailed analysis of
numerous variables.  The pet owners were often difficult to reassure about the need for
repeated invasive endoscopic procedures.  Complete studies could not be performed on
cats because of limited patient material.
The reliability of diagnostic methods for detecting gastric helicobacters is a strong
determinant of whether or not bacteria are found.  Therefore, application of different
methods of assessing helicobacter status had to be evaluated in order to allow study of the
association between helicobacters and unspecified signs of gastritis often seen in dogs and
cats.  Such  comparison between diagnostic methods for the detection of helicobacters in
animals had not been performed earlier.  The methods used were adaptations of diagnostic
techniques for human H. pylori.  The sample collection in these methods requires
endoscopy, which is an invasive procedure,  making  the diagnosis somewhat difficult.
Serologic methods, UBT, PCR, and in situ hybridization assays are effective methods  for
demonstrating human H. pylori (Li et al 1996, de Boer 1997), but they were not available
for the present studies.  Although culturing of canine and feline helicobacters has been
difficult and often unrewarding, our research team has been successful in isolating new
helicobacter species, H. bizzozernonii (Hänninen et al 1995 & 1996) and H. salomonis
(Jalava et al 1997), for the first time. 
Histologic criteria were important in study of the association between helicobacters
and gastritis.  Objective standards to categorize canine and feline gastritis were lacking,
and therefore a visual analogue scale was created for histologic evaluation of gastric biopsy
specimens during the present studies. 
Considering that the diagnostic methods used for verifying the success of the
helicobacter eradication were valid for this purpose, human eradication therapies seemed
to be effective also in dogs.  An experimental infection study enhanced the understanding
of the routes of transmission.
9.1.Diagnostic methods for detecting gastric helicobacters
Of the methods studied - brush cytology, the urease test, histologic examination,
TEM, and culture (I) - only brush cytology revealed gastric helicobacters with high
reliability regardless of sample site; it can therefore be considered the method of choice for
demonstrating helicobacters.  It is easy to perform by endoscopy, and a relatively large area
can be sampled.  The result can also be obtained almost immediately if a rapid staining
reagent (Romanovsky type stain) is used.  Helicobacters are recognized easily from a brush
cytology specimen if they are moderate to numerous in number, whereas it is time-
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consuming to detect a small number of bacteria or to conclude that they are absent.  The
characteristic spiral morphology of organisms can be discerned, although species
identification is impossible.  Brush cytology can be used as a semiquantitative method for
evaluating the number of helicobacters.  Although this method is able to detect
helicobacters at a very low density, the results do not always correlate with histology or the
urease test.  In the same animal,  histologic examination may demonstrate a high number
of helicobacters, and the urease test may produce a positive result quickly, indicating high
number of organisms, whereas brush cytology shows only a few bacteria.  The small
number of helicobacters in brush cytology when the correct number is actually high, may
be attributable to inconsistency in the quality of the mucus specimen obtained or the site
from which the specimen was collected.  Gastric contents may also influence this method
if debris reaches the slide covering the bacteria.  If, however, brush cytology testing is not
performed, but only histologic examination and urease testing,  helicobacters may be
missed, if low in number.  For this reason, some failure to detect helicobacter-positive
cases after eradication may have occurred (IV).  In some cases, brush cytology detected
helicobacters when histologic examination and the urease test gave negative results (III,
IV).  False-positive results with brush cytology might be possible if helicobacters originate
from contaminated instruments or endoscopes.  Even if the instruments and equipment are
cleaned and disinfected properly, dead bacteria may cause a false-positive result in brush
cytology.  In addition, mucus strings which look like bacteria may cause misinterpretation.
Hazell et al (1987) showed that the number of positive results in the urease test
increased with the time during which the test reagent was applied, especially when the
helicobacter count was low.  The same was noted in Study I, because more results were
positive that were obtained when the test was read at 60 min than at 30 min.  When a high
number of helicobacters were present, the urease test a gave positive result usually in 15
minutes (III).  However, the urease test may give some false negative results when a low
number of helicobacters are present, as in samples from the canine antrum (I).  False-
positive results are thought to be rare, but can occur if the test produces a positive result
after 12 to 18 hours; in such instances, a positive result may be due to other urease-
producing gastric bacteria such as Proteus mirabilis or Pseudomonas aeruginosa, although
late-occurring color change may also be possible if the number of helicobacters is low
(Goldie et al 1989).  In general, however, for the detection of gastric helicobacters, the
urease test can be considered fairly reliable.
The advantage of histologic examination over brush cytology and the urease test is
that the location of helicobacters in the gastric glands and parietal cells, and the presence
of inflammatory cells as well as tissue changes, can also be evaluated.  Its disadvantage is
the length of time needed to obtain results.  The mucus overlying the epithelium and
consequently any superficial helicobacters may be easily wiped away if biopsy specimens
are handled and processed carelessly.  This was taken into account when the colonization
density of helicobacters was graded in Study III by grading moderate colonization density
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in two separate ways (Table 3).  In the present studies, gastric helicobacters could be
recognized histologically in HE-stained sections in most cases.  The Warthin-Starry
technique has been described as the most satisfactory staining method if one is searching
only for spiral organisms (Stevens 1990).  Giemsa staining may visualize helicobacters
better than HE staining.  However, when HE-stained specimens negative for helicobacters
were stained with Warthin-Starry (I) or Giemsa (IV), both of these staining methods
succeeded on only one occasion in revealing helicobacters where HE staining had failed.
New sections were cut for other staining methods in these studies, and it may have been
possible that gastric helicobacters were uncovered when more sections were cut from a
paraffin block, since one section is approximately as thick as the cross-section of a
helicobacter, a fact that needs to be considered in cases where HE-stained specimens fail
to reveal bacteria. Therefore, to be assured that no helicobacters are present in the
histologic gastric biopsy specimen, the whole paraffin block should be sectioned and
evaluated, which is, however, time-consuming and impractical.
 Spiral organisms were seen by TEM in all canine and feline specimens examined,
suggesting that their number was high.  Gastric helicobacters are, however, not always seen
in a TEM specimen, since their distribution in the stomach may be patchy, and the sample
is small and thin (McNulty et al 1989a).  According to present findings, TEM is  most
rewarding to perform on urease-positive cases which indicate a high number of bacteria.
The typical morphology of the bacteria, readily seen under the electron microscope, can be
used for purposes of preliminary identification (Utriainen et al 1997).  H. felis is easy to
identify due to its periplasmic fibrils.  However, although atypical non-fibrillated H. felis
has recently been described (Eaton et al 1996), but it has not been isolated in Finland
(Jalava et al 1998).  Atypical H. felis, and H. bizzozeronii, H. salomonis, and human “H.
heilmannii” are indistinguishable from each other by TEM because of similar morphologic
features, but some conclusions may be made on the basis of the size of the bacterium.  The
most common helicobacter identified here in TEM specimens was a large spiral bacterium
without periplasmic fibrils both in dogs and cats, and mixed infections with large spiral
bacterium and H. felis in dogs.
The results of Studies I-III confirmed that culture of canine and feline gastric
helicobacters is demanding and often unsuccessful.  Fasting of the animal is crucial to
decrease the number of contaminating organisms, and a fresh biopsy specimen, freshly
prepared moist media, a long incubation period, and high atmospheric humidity are
necessary to optimize bacterial growth (Jalava et al 1998).  Despite that fact, culture and
identification of a number of helicobacters was successful, in up to 50% of dogs and 17%
of cats (I-III), in contrast to the meager results of other studies (Weber and Scmittdiel 1962,
Henry et al 1987, Eaton et al 1996, Papasouliotis et al 1997, Neiger et al 1998).  Culture is
useful because isolates, if obtained, can be accurately characterized.  H. bizzozeronii with
or without H. felis was the most common species both in clinically healthy and affected
dogs (III).  It was surprising that H. felis was diagnosed in only one cat by culture (II)
57
because it has been reported to be a common finding in cats (Lee et al 1988).  Mixed
infections with H. felis and other Helicobacter species are also common in cats (Lee et al
1988) as well as in dogs (Lockard and Boler 1970), which in the case of dogs agrees with
present results.  The true number of mixed infections may have been even higher than
detected, because TEM and culture may detect one species but fail to detect others.  TEM
and culture may also identify different species, indicating mixed infections, although only
one species is detected by each of these methods.
9.2.Prevalence and colonization density
The high prevalence of gastric helicobacters, 95 to 100% in dogs and 60% in cats,
confirmed the results from other studies (Weber et al 1958, Henry et al 1987, Eaton et al
1996, Yamasaki et al 1998).  High prevalence rates are suspected to appear in animals
living in colonies (Weber et al 1958, Henry et al 1987, Eaton et al 1996);  for instance, all
the beagle dogs that were kept in one laboratory environment had helicobacters (Henry et
al 1987).  However, lower prevalences  have also been reported (Geyer et al 1993, Otto et
al 1994, Hermanns et al 1995).  The size of the biopsy specimen may have an influence on
the prevalence rates as well.  It may be more difficult to detect helicobacters in an
endoscopically obtained pinch biopsy specimen than in a large, full-thickness biopsy, even
though biopsy size did not affect the present results.  Prevalence of the organisms may vary
geographically.  All dogs in the present studies were from urban areas of southern Finland,
where the density of dogs is higher than in northern Finland.  Consequently, this could
have resulted in more contacts among these dogs, leading to enhanced transmission. 
Limitations of the earlier studies may have included the method of selection of the
dogs, such as obscure clinical history or experimental status of the animals, or the
medications administered to them.  All dogs in Study III were pets originally obtained from
breeders, and the clinical and medical history of each dog was known.  Therefore, the
effects of drugs on the prevalence of helicobacters and on gastric histology could be better
judged. 
The similar prevalence rate and colonization density of gastric helicobacters both in
healthy and affected dogs (III) suggests that these bacteria may be a part of the normal
gastric flora. The prevalence rate was also equal in dogs of all ages and in both genders,
and no association was detected between age and colonization density of helicobacters.
Previous studies have mostly involved adult dogs of various ages.  However, in cats,
helicobacters have been found more often in adult cats than in kittens (Weber et al 1958,
Otto et al 1994). 
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9.3.Topography
To verify the presence of gastric helicobacters, a biopsy sample from the corpus,
fundus, or cardia proved to be reliable, because helicobacters appeared most frequently and
were the highest in number in these three gastric regions.   Thus, it was concluded that in
clinical practice one sample from gastric regions other than the antrum (including the
pylorus) may be sufficient to demonstrate the presence of gastric helicobacters, contrary to
earlier reports of experimental infection studies.  When gnotobiotic beagle dogs were
infected with H. pylori, most of the bacteria were found in the fundus (Radin et al 1990),
whereas when they were infected with H. felis, the heaviest colonization was detected in
the fundus and antrum (Lee et al 1992b).  Handt et al (1994) demonstrated H. pylori
mostly in the corpus and antrum in cats.  However, the terminology describing the
anatomic regions of the canine and feline stomach may vary between studies, making
accurate comparison of results difficult.  Different results may also be attributable to the
particular Helicobacter species used in the studies and to the origin of the dogs. The
animals in the present studies were not gnotobiotic but had presumably normal gastric
flora, a fact which may have affected the results.  In this respect, the present results are
likely to be clinically more relevant than those of the experimental studies.  The
distribution of helicobacters in dogs differs somewhat from that of human H. pylori, which
predominantly colonizes the antrum (Genta and Graham 1994).
The location of gastric helicobacters on the mucosal surface and in gastric pits as
well as in gastric glands and in parietal cells was consistent with earlier reports on dogs
and cats (Weber et al 1958, Henry et al 1987, Geyer et al 1993, Hermanns et al 1995, Eaton
et al 1996, Yamasaki et al 1998).  This is in contrast to human H. pylori, which is located
mainly on the mucosal surface and in gastric pits (Thomsen et al 1990), although one paper
reports  H. pylori also in parietal cells (Chen et al 1986).  In a colony of cats, H. pylori was
located only in the superficial mucus layer and in the gastric pits, whereas in other cats
having different Helicobacter species, the organisms were seen also in parietal cells (Handt
et al 1994).  Thus, it seems that canine and feline helicobacters may have greater affinity
to parietal cells than does H. pylori in man; this could be related to the predominance of
the bacteria observed in gastric regions other than the antrum of dogs and cats. 
9.4.Helicobacters and gastritis
In order to perform a reliable histologic assessment, high-quality biopsy specimens
are  required; they must be of adequate size and depth, properly oriented, and free of
artifacts such as the  crushing and stretching that distort gastric biopsy specimens.
Artifacts can be avoided by the use of proper biopsy forceps and biopsy techniques.
Overinflation of the stomach will flatten gastric folds and result in samples too small and
superficial (Tams 1990).  In contrast to other gastric regions, the antrum is difficult to
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sample, and therefore, unless macroscopic changes are visible, some researchers do not
routinely biopsy the antrum (Tams 1990).  A great number of antral biopsy specimens had
to be excluded also in the present studies because of poor quality. 
Gastric inflammation was a common finding in histologic specimens in dogs and
cats, and mononuclear cells were more common than lymphocyte aggregates, neutrophils,
or eosinophils.  In the prevalence rates and densities of inflammatory parameters between
gastric regions, some discrepancies occurred in dogs: in Study II, the antrum was more
inflamed with plasma cells than was the corpus, whereas in Study III, mononuclear cells
were distributed quite evenly throughout the stomach.  These discrepancies may have been
attributable to different criteria for histologic assessment.  Neutrophils seem not to play as
important a role in canine and feline gastritis as they do in H. pylori gastritis in man (Fox
et al 1991a, Handt et al 1994).  In dogs, there was no positive correlation between degree
of gastric inflammation and  colonization density of helicobacters, in agreement with some
reports (Eaton et al 1996) but in conflict with others (Henry et al 1987, Yamasaki et al
1998).  On the contrary, more lymphocytes were detected in helicobacter-positive cats
having numerous helicobacters than in negative cats (II).  In addition, lymphocyte
aggregates were seen only in positive cats, indicating that in cats helicobacters and gastric
inflammation may have some connection.
Criteria for histologic evaluation always affect the results.  Since generally accepted
objective criteria do not exist for dogs and cats, researchers have usually created their own
criteria (Handt et al 1994, Eaton et al 1996), or they have used the Sydney system
developed for categorizing human gastritis (Geyer et al 1993, Yamasaki 1998).  In Study
II, the modified Sydney system was applied for histologic diagnoses, and the results
indicated that asymptomatic mild chronic gastritis is common in apparently healthy dogs
and cats suggesting that the criteria used to diagnose human gastritis may not be suitable
for these animals.  For this reason and also because the biopsy sample was changed from
full-thickness biopsy to endoscopic biopsy, the grading system in Studies III and IV was
changed.  A modified visual analogue scale from the updated Sydney system in humans
(Dixon et al 1996) was developed because exact counting of each variable is laborious to
perform routinely, and difficult in gastric biopsy specimens, most of which are
heterogenous in appearance and often contain artefacts.  More inflammatory cells were
allowed in normal gastric histology, because seldom, if ever, is a gastric specimen without
inflammatory cells.  The importance of lymphocyte aggregates is debatable in dogs and
cats; they have been speculated to be markers of gastric inflammation, but one report
considers them a normal finding (Kolbjørnsen et al 1994).  On the other hand, in humans,
lymphoid follicles are linked with H. pylori-associated gastritis (Genta et al 1993a, Zaitoun
1995).  Because no data were available on the significance of intraepithelial inflammatory
cells, they were considered only when their number was clearly increased.
The new criteria, although modified to be less strict, still showed that mild chronic
gastritis seems to be a common histologic diagnosis that is not associated with clinical
60
signs.  It was surprising that many clinically healthy dogs had histologically verified mild
to severe chronic gastritis, whereas many dogs with upper gastrointestinal signs had none
or only mild gastritis.  Most of the affected dogs had suffered from upper gastrointestinal
signs over a long period before referral to endoscopy, and many had been treated with
antibiotics and gastric protectants such as cimetidine and sucralphate more than two weeks
prior to endoscopy.  Therefore, in some affected dogs with mild chronic gastritis, previous
medications may have played some role in histologic changes, although the effects of these
drugs on gastric histology have not been reported in the literature.  These findings raise
concern about clinical interpretation of histologically verified chronic gastritis.  Medication
may also have reduced the number of gastric helicobacters, which could explain the mild
colonization density of the bacteria in some affected dogs. 
 In addition to gastritis, degenerative lesions of parietal cells in conjunction with
helicobacters have been found not only in affected but also in clinically healthy animals,
as was demonstrated also in the present studies (II, III).  These lesions have been supposed
to indicate the pathogenicity of gastric helicobacters (Weber et al 1958, Henry et al 1987,
Geyer et al 1993, Hermanns et al 1995), but it is unresolved whether helicobacters colonize
degenerating parietal cells or induce their degeneration.   Previous studies have shown an
association between gastric helicobacters and chronic gastritis not only in cats but also in
dogs (Lee et al 1992, Geyer et al 1993, Handt et al 1994, Hermanns et al 1995); however,
this could not be established in the present studies.  That the colonization density of gastric
helicobacters showed no correlation with histologic changes suggests that helicobacters
alone may not be responsible for those changes.  Another explanation may be that different
Helicobacter species or strains may differ in pathogenicity.
Only negative correlations were evident between the colonization density of
helicobacters and the number of some inflammatory variables (mononuclear cells and
neutrophils) in clinically healthy and affected dogs, but the mechanism and significance of
this phenomenon remained unclear.  Severe gastritis may decrease acid secretion, and
consequently the number of bacteria; the small number of helicobacters may also be
explained by destruction of bacteria due to an immune response induced by gastritis.
Gastric pH measurement should be addressed in future studies to verify these hypotheses.
Because there were no differences between healthy and affected dogs in the
prevalence rate or colonization density of gastric helicobacters or any positive association
between colonization density and number of inflammatory variables, it would appear that
helicobacters may be part of the normal gastric flora.  However, the host response must
also be considered, because specific dogs may react differently to bacterial flora.  Large
variation in severity of gastric inflammation has been reported in inbred and congenic
mouse strains infected with H. felis (Mohammadi et al 1996), indicating that the genetic
background of the host may play an important role in the clinical outcome of Helicobacter
infections.  In addition, because it was impossible to find a helicobacter-negative control
group of dogs, conclusions could not be drawn regarding helicobacters’ capability to
61
induce gastritis.  Observed from the histologic aspect only, the clinically healthy status of
an animal does not indicate whether or not an organism is pathogenic or part of the normal
flora.  Histologic criteria may need to be adjusted when the pathogenicity of these
organisms has been resolved. Further studies are required to elucidate the role of the host
as well as to clarify the significance of gastric helicobacters.
Mixed infections are common in dogs (Lockard and Boler 1970, Lee et al 1988),
which agrees with results of Study III.  H. bizzozeronii with or without H. felis was the
most common species both in clinically healthy and in affected dogs; H. salomonis was
identified only in a few cases.  Successful isolation of a number of Helicobacter species
made it possible to study the association between the number of species and degree of
gastric inflammation, in order to resolve the possibility that one species might cause less
inflammation than several species.  The number of individual species isolations was too
small to allow evaluation of any association between Helicobacter species and
inflammation, an evaluation which could have provided more information on the possible
pathogenicity of different species.  Still, that no association could be demonstrated between
number of Helicobacter species and degree of inflammation, may suggest that the
Helicobacter species in the present studies seem to have been nonpathogenic.  However,
further studies are needed to establish the pathogenicity of various Helicobacter species
and strains.  For this purpose, successful laboratory culture of these organisms is needed,
to enable the determination of  biochemical, serological, molecular, and pathogenic
features of the isolates.
9.5.Eradication
The follow-up study (IV) showed that the triple therapy used in human medicine to
eradicate H. pylori seems also to be effective for eradicating canine gastric helicobacters.
However, the result might have been less obvious if some uncontrolled variables, such as
the time period between control endoscopies, could have been eliminated, or had more
sensitive methods, such as the UBT or PCR assay (Li et al 1996, de Boer 1997), been used.
These two methods are not used routinely in veterinary medicine at present, nor do they
have 100% specificity or sensitivity.  The use of more than one diagnostic method
increases the sensitivity of helicobacter detection (van der Ende et al 1997).  A ten-day
duration of treatment appears to be long enough to eradicate gastric helicobacters.  In
humans, H. pylori status is usually evaluated four weeks after cessation of therapy, during
which time recrudescence of the bacteria is likely to occur (van der Ende et al 1997).  If
this applies also to dogs, some of the control endoscopies may have been performed too
soon after triple therapy (IV).
Metronidazole resistance may explain the eradication failure, a fact supported by the
finding that one of the dogs that remained helicobacter-positive after triple therapy became
negative with tetracycline and omeprazole (IV).  Metronidazole resistance in H. pylori has
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been reported (Glupczynski et al 1990, Bell et al 1991, Seppälä et al 1992, Logan et al
1993) and it seems to occur also in canine gastric helicobacters, as was shown in the
transmission study (V).  Only a limited number of H. bizzozeronii or H. salomonis isolates
have been studied thus far, but they all have been sensitive to metronidazole (Hänninen et
al 1996).  In humans, about 20% of H. pylori isolates are resistant to metronidazole (Noach
et al 1994).  Molecular typing of metronidazole-resistant H. pylori strains in one study was
identical in most cases before and after the unsuccessful therapy (Owen et al 1993).  That
metronidazole is used for treating gastrointestinal disorders and anaerobic infections in
veterinary medicine may explain the resistance of the bacteria. 
The general treatment protocol for H. pylori in humans has changed slightly since the
beginning of the follow-up study (IV) five years ago.  Instead of the bismuth subcitrate,
amoxicillin, and metronidazole, the first-choice treatment today consists of a proton-pump
inhibitor (e.g., omeprazole) together with amoxicillin and either nitroimidazole derivatives
(metronidazole or tinidazole) or clarithromycin (European Helicobacter Pylori Study
Group 1997).  If triple therapy fails, the second-choice therapy is a proton-pump inhibitor
and bismuth subcitrate with tetracycline or amoxicillin and metronidazole.  In future, it
may be worthwhile to test the eradication of canine gastric helicobacters according to these
recommendations.  Other drugs may also induce suppression of gastric helicobacters
without eradicating them, drugs such as tylosin (personal experience) and sucralfate (Louw
et al 1992).
Although triple therapy alleviated upper gastrointestinal signs to some extent, it
failed to resolve the signs totally in any dog.  Neither was there any difference in clinical
response to triple therapy between negative dogs and dogs that remained positive.  On the
contrary, clinical signs subsided to a great extent with other treatments after gastric
helicobacters already had been eradicated in most dogs.  This is in contrast to humans, in
which clinical signs caused by H. pylori-induced peptic gastric and duodenal ulcers resolve
after eradication of H. pylori (Labenz and Börsc 1994), but it is still controversial what role
H. pylori plays in non-ulcer dyspepsia (Talley and Hunt 1997).  The results of triple
therapy  in the present study should, however, be interpreted cautiously because of the
limited number of cases, i.e., seven dogs became negative and two remained positive with
this therapy, and consequently, further studies are needed to draw final conclusions in this
matter.  The reason that the triple therapy had an alleviating effect on the clinical signs in
dogs remained unclear.  Although the primary causes of clinical signs may remain obscure,
one or more of the three components in this therapy would be likely to alleviate clinical
signs at least to some degree.  The fact that the additional therapies prescribed, although
not known to affect helicobacters, did control clinical signs in dogs better than did triple
therapy did not support the view of gastric helicobacters being alone responsible for their
upper gastrointestinal signs.  A placebo control group might have been of value when the
eradication therapy was assessed, but was not included in Study IV because of the pet
owners’ reluctance.  Due to some diversity in clinical signs, problems originating from the
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small intestine should also be considered as a possible cause for such clinical signs,
although obvious intestinal problems were ruled out by performance of routine
hematologic and biochemical analyses, and serum folate and cobalamine measurement;
fecal flotation for parasites, and abdominal radiographs.
 Histologically verified H. pylori-induced gastric inflammation in humans clearly
decreases within one year of eradication of the bacteria (Valle et al 1991, Genta et al
1993a, Witteman et al 1995).  Mild chronic gastritis, the most common histologic
diagnosis in the dogs studied, persisted at almost the same level after eradication therapies
as well as after other treatments, and also during the long-term follow-up period.  The
time-period between treatments and endoscopy may have affected the histologic diagnoses,
because inflammatory changes might have persisted for a longer period than assumed after
triple therapy.  However, no published data are available on how quickly inflammatory
changes disappear after eradication therapy in dogs or whether they resolve at all, and this
matter remained unresolved here as well.  Chronic gastritis may also have persisted
because the eradication therapy had merely suppressed gastric helicobacters - assuming
that the bacteria had been solely responsible for the inflammation in the first place.  The
reason for the eosinophilic activity in dogs with upper gastrointestinal signs remained
obscure.  In humans, eosinophilic infiltration is suggested to be associated with H. pylori
gastritis (McGovern et al 1991), whereas any association between eosinophils and canine
gastric helicobacters needs clarification.  Dietary hypersensitivity and internal parasites
may increase the number of eosinophils in the gastric mucosa, but since these conditions
were ruled out at study entry, it is unlikely that they would have been responsible.
Gastric helicobacters appear to recur after eradication treatment.  Reinfection in the
case of successful eradication and recrudescence in the case of mere suppression are
impossible to distinguish without identification of Helicobacter species pre- and post-
treatment and similarity-testing of the isolates (van der Ende et al 1997).  Culture of canine
gastric helicobacters is difficult, and even if isolation succeeds, the high frequency of
mixed infections in dogs may cause misinterpretation if only one species is identified.  All
the dogs that attended the long-term follow-up had become helicobacter-positive (IV), and
had contacts with either another dog in the household or other dogs; this fact supports the
transmission of helicobacters via the fecal-oral and/or oral-oral routes (Mendall 1997).
Although the helicobacter status of the contact dogs was unknown, the likelihood for their
being positive was strong because of the high prevalence of these organisms in dogs in
general (Weber et al 1958, Henry et al 1987, Eaton et al 1996, Yamasaki et al 1998).
Reinfection was most likely the cause of reappearance of gastric helicobacters in the dogs
of the follow-up study because recrudescence of H. pylori occurs in most cases within four
weeks after cessation of therapy (van der Ende et al 1997), but the bacteria in these dogs
remained absent until the end of the first follow-up period, which ranged from one to
twelve months (IV).  However, triple therapy in some dogs may have merely suppressed
gastric helicobacters to undetectable levels, in which case recurrence is more or less
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inevitable.  In humans, recurrence of H. pylori infection is low (3.4%) after successful
eradication with triple therapy, and when it takes place, it appears to occur most commonly
within the first year after treatment (Cutler and Schubert 1993).
9.6.Transmission
Early natural transmission of the gastric helicobacters in dogs either from the dams
or among puppies received support in Study V.  In humans, several studies support the
acquisition of H. pylori infection early in life.  A high level of positive sera (16.5-74%) is
found among children under two years of age in developing countries (Mégraud et al 1989,
Klein et al 1994, Oliveira et al 1994), whereas in many developed countries, children less
than six years old often do not have antibodies to H. pylori (Kontiainen et al 1994).
Correlations have been reported between colonization and age, low socioeconomic status,
and overcrowding (Webb et al 1994).  Although the infection route was not resolved, oral-
oral transmission is likely because close nursing contact between dams and puppies during
the lactation period will inevitably predispose puppies to the gastrointestinal infectious
agents of their dams. Helicobacters could not be isolated from the fecal samples either of
the dams nor of the puppies by the method used.  Any transmission via personnel was
prevented by strict hygiene, and via endoscopic equipment by thorough washing and
disinfecting with glutaraldedyde, which has been shown to be effective in preventing cross-
transmission of H. pylori; disinfection time should be at least 20 minutes in manual
cleaning (Akamatsu et al 1996, Cronmiller et al 1999).  In addition, the puppies had no
contacts with other dogs.
Triple therapy seemed only to suppress rather than eradicate the infection of the
dams.  However, the number of helicobacters decreased to the level at which the urease test
and brush cytology were negative after the treatment.  The reason for unsuccessful
treatment can be explained by the metronidazole-resistance of the isolates.  Identical
ribotyping and similar PFGE patterns of the isolates cultured from dam B before therapy,
five months after therapy, and  two years later (unpublished results) were suggestive for
permanent infection of that dam with the same metronidazole-resistant strain of
Helicobacter species.  The infection level of dam A was considered lower than that of dam
B because during the study, the urease test of the biopsy sample from dam A was either
negative or weakly positive, and culture unsuccessful.
Although two of the puppies in the non-challenged group were born from dam A and
two from dam B, the three H. salomonis-positive ones had identical Helicobacter
genotypes confirmed by ribotyping and PFGE pattern analysis.  At the beginning of the
experiment, the animals in the challenged group were probably also infected with an H.
salomonis strain originating from the dams, but a heavy experimental infection with H.
bizzozeronii CCUG 35045 masked and suppressed the original infection.  PFGE analysis
revealed that the puppies of the non-challenged group were infected by the isolate from
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dam B and not from dam A.  Most probably, dam B had infected two of her puppies during
the lactation period, and her puppies further infected the puppies of dam A in the group
during the experiment. 
Ribotyping of the present isolates revealed that the patterns of dams and puppies in
the nonchallenged group were identical and differed from the patterns of unrelated strains.
However, PFGE analysis was shown to be a better method for distinguishing between
isolates than ribotyping, because it was able to distinguish the isolates of dam B from the
isolate of dam A.  Similarly, REA analysis suggested that the isolates of the dams were
highly related but not identical.  General genetic diversity of H. bizzozeronii and H.
salomonis (Finnish strains) have been studied, showing that unrelated strains produce
different ribo- and PFGE patterns (unpublished results), a finding supported by the present
data.
9.7.Discussion summary
Despite these thorough studies, an unambiguous answer whether or not canine or
feline gastric helicobacters are significant cannot be given, i.e., whether or not they may
induce changes in gastric histology and signs of gastritis.  However, several important
factors were clarified: the high prevalence of the bacteria both in healthy and affected dogs
as well as in healthy cats, the usefulness of routine diagnostic methods, and the efficacy of
human triple therapy for eradicating helicobacters.  The transmission of helicobacters was
also elucidated.  Further studies are needed to resolve the role of gastric helicobacters, for
instance, placebo-controlled therapy trials and verification of the results by more sensitive
methods.   A detailed characterization of Helicobacter species and strains is also needed
to establish their pathogenicity.  The newly established zoonotic potential of H.
bizzozeronii raises concerns in public health which should be dealt with.
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10. CONCLUSIONS
1. Brush cytology was the method of choice for detecting gastric helicobacters.  The
urease test and histological examination were also of value.  TEM produced positive
results in the majority of cases; culture gave less positive results.  Although the two latter
methods are more demanding, they are needed to identify different Helicobacter species.
Consequently, TEM and culture may assume greater importance if future studies show that
different species or strains of canine and feline helicobacters differ in pathogenicity. 
2. Gastric helicobacters were common inhabitants of the stomachs of dogs, with their
prevalence varying from 95% in dogs with signs of gastritis to 100% in healthy dogs.
Colonization density of helicobacters is also frequently high in both healthy dogs and
affected ones.  Age of dogs was not associated with colonization density.  Helicobacters
proved to be common also in cats but to a lesser extent (60%) than in dogs. 
3. Gastric helicobacters can be  found in all regions of the stomach, although less
frequently and in the smallest quantity in the antrum of dogs.  In cats, such regional
differences seem not to be evident.  Only one sample from the cardia, fundus, or corpus
seems to be sufficient to demonstrate the presence of helicobacters in dogs and cats.
Canine and feline helicobacters are located from the surface mucus down to the gastric pits
and parietal cells.
4. Histologically verified chronic gastritis was very common in dogs, both in clinically
healthy dogs (48%) and in dogs with upper gastrointestinal signs (81%).  The colonization
density of helicobacters could not be positively connected with inflammation of the gastric
mucosa in either group.  However, in cats, gastric helicobacters were associated with
changes comparable to those of chronic gastritis.  In dogs, a cause-and-effect relationship
between gastric histology and clinical signs remained unclear, because all healthy dogs and
the majority of affected dogs were helicobacter-positive, but more of the affected dogs had
histologically verified chronic gastritis.  It still remains to be demonstrated whether certain
Helicobacter strains have specific virulence factors that may induce gastritis in dogs and
in cats, and whether any host-associated factors play a role during development of gastritis.
The histologic criteria for human gastritis as such seem not to be suitable for dogs and cats,
whereas the modified visual analogue scale proved to be a satisfactory method. 
5. Rough identification of  Helicobacter species according to their morphologic
features by TEM included H. felis with periplasmic fibrils, and large spiral non-fibrillated
bacteria with a morphology resembling either that of H. bizzozeronii, H. salomonis, or non-
fibrillated H. felis.  Species accurately identified by culture comprised H. bizzozeronii, H.
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felis, and H. salomonis.  H. pylori was not detected in any dog or cat.  The number of
Helicobacter species seemed to have had no effect on degree of gastric inflammation.
6. Human triple therapy consisting of amoxicillin, metronidazole, and bismuth
subcitrate appeared to be generally effective in eradicating canine gastric helicobacters.
The alternative drugs tetracycline and omeprazole seemed also to be effective.
Helicobacters do not appear to be a major etiologic factor in canine upper gastrointestinal
disorders, since it was not demonstrated that these organisms alone were responsible for
the clinical signs or gastric histologic changes. Helicobacters seemed also to recur after
eradication, either because of reinfection or of recrudescence, without inducing clinical
signs.  Therefore, routine therapy for eradicating canine helicobacters appears not to be
warranted or cost-effective until further evidence emerges of their pathogenicity. 
7. Canine gastric helicobacters were acquired as early as during the lactation period,
and the dam was the reservoir in the transmission.  Puppies also infected each other.  The
infection route, however, whether oral-oral or fecal-oral, remains to be resolved.  The
transmission and persistence of the infecting strain could be demonstrated by molecular
methods. Metronidazole-resistence may explain the persistence of helicobacters despite the
eradication therapy.  PFGE analysis seems to be better than ribotyping in distinguishing the
similarity of the isolates.  
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